{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "from PyPDF2 import PdfReader\n",
    "import os\n",
    "import pandas as pd\n",
    "import glob\n",
    "\n",
    "from nltk.corpus import stopwords\n",
    "from nltk.stem import WordNetLemmatizer  \n",
    "import re\n",
    "\n",
    "from sklearn.ensemble import RandomForestClassifier\n",
    "from sklearn.linear_model import LogisticRegression\n",
    "from sklearn.metrics import confusion_matrix,classification_report"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_pdfs_in_directory(directory_path):\n",
    "    # Use glob to get all PDF files in the directory\n",
    "    pdf_files = glob.glob(os.path.join(directory_path, '*.pdf'))\n",
    "    return pdf_files\n",
    "pdf_not_relevant = get_pdfs_in_directory('test_data/not_relevant')\n",
    "pdf_relevant = get_pdfs_in_directory('test_data/relevant')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "def text_extract(reader):\n",
    "    doc_text = \"\"\n",
    "    num_pages = len(reader.pages)\n",
    "    for i in range(num_pages):\n",
    "        page_text = reader.pages[i].extract_text() + \" \"\n",
    "        doc_text += page_text\n",
    "    return doc_text\n",
    "\n",
    "def get_info(path,relevant):\n",
    "    with open(path, 'rb') as f:\n",
    "        pdf = PdfReader(f)\n",
    "        info = pdf.metadata\n",
    "        author = info.author if '/Author' in info else None\n",
    "        title = info.title if '/Title' in info else None\n",
    "        subject = info.subject if '/Subject' in info else None\n",
    "        keywords = info['/Keywords'] if '/Keywords' in info else None\n",
    "        number_of_pages = len(pdf.pages)\n",
    "        text = text_extract(pdf)\n",
    "        relevance = 1 if relevant else 0\n",
    "    return [author, title, subject, keywords, number_of_pages, text, relevance]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "all_info = []\n",
    "for pdf in pdf_not_relevant:\n",
    "\tall_info.append(get_info(pdf,relevant = False))\n",
    "for pdf in pdf_relevant:\n",
    "\tall_info.append(get_info(pdf,relevant = True))\n",
    "harvest_nlp = pd.DataFrame(all_info,columns = ['author','title','subject','keywords','num_pages','text','is_relevant'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>author</th>\n",
       "      <th>title</th>\n",
       "      <th>subject</th>\n",
       "      <th>keywords</th>\n",
       "      <th>num_pages</th>\n",
       "      <th>text</th>\n",
       "      <th>is_relevant</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>ECDC</td>\n",
       "      <td>Effectiveness and cost-effectiveness of antena...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>37</td>\n",
       "      <td>TECHNICAL  REPORT\\nEffectiveness and cost-  \\n...</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>45</td>\n",
       "      <td>SPECIAL REPORT\\nImplementing the  \\nDublin Dec...</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>15</td>\n",
       "      <td>SPECIAL REPORT\\nThematic report:  \\nSex worker...</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>36</td>\n",
       "      <td>TECHNICAL  REPORT\\nRisk assessment on HIV in G...</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>ECDC</td>\n",
       "      <td>Chlamydia - Annual epidemiological report</td>\n",
       "      <td>Chlamydia, surveillance, monitoring</td>\n",
       "      <td>Chlamydia, surveillance, monitoring</td>\n",
       "      <td>9</td>\n",
       "      <td>\\nSuggested citation: European Centre for Dis...</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  author                                              title  \\\n",
       "0   ECDC  Effectiveness and cost-effectiveness of antena...   \n",
       "1   None                                               None   \n",
       "2   None                                               None   \n",
       "3   None                                               None   \n",
       "4   ECDC         Chlamydia - Annual epidemiological report    \n",
       "\n",
       "                                subject                             keywords  \\\n",
       "0                                  None                                 None   \n",
       "1                                  None                                 None   \n",
       "2                                  None                                 None   \n",
       "3                                  None                                 None   \n",
       "4  Chlamydia, surveillance, monitoring   Chlamydia, surveillance, monitoring   \n",
       "\n",
       "   num_pages                                               text  is_relevant  \n",
       "0         37  TECHNICAL  REPORT\\nEffectiveness and cost-  \\n...            0  \n",
       "1         45  SPECIAL REPORT\\nImplementing the  \\nDublin Dec...            0  \n",
       "2         15  SPECIAL REPORT\\nThematic report:  \\nSex worker...            0  \n",
       "3         36  TECHNICAL  REPORT\\nRisk assessment on HIV in G...            0  \n",
       "4          9   \\nSuggested citation: European Centre for Dis...            0  "
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "harvest_nlp.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Remove/Replace Nulls"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "author         43\n",
       "title          48\n",
       "subject        56\n",
       "keywords       50\n",
       "num_pages       0\n",
       "text            0\n",
       "is_relevant     0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "harvest_nlp.isna().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "72"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(harvest_nlp)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['author', 'title', 'subject', 'keywords', 'num_pages', 'text',\n",
       "       'is_relevant'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "harvest_nlp.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "#replace empty strings with Unknown\n",
    "harvest_nlp.replace('','Unknown',inplace=True)\n",
    "harvest_nlp.replace(' ','Unknown',inplace=True)\n",
    "\n",
    "#fill na values, drop ones that aren't necessary (only dropped one since there isn't too much data)\n",
    "harvest_nlp.fillna({'author': 'Unknown',\n",
    "\t\t\t\t\t\t'title': 'Unknown',\n",
    "\t\t\t\t\t\t'subject': 'Unknown',\n",
    "\t\t\t\t\t\t'keywords': 'Unknown',\n",
    "\t\t\t\t\t\t},inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "author         0\n",
       "title          0\n",
       "subject        0\n",
       "keywords       0\n",
       "num_pages      0\n",
       "text           0\n",
       "is_relevant    0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "harvest_nlp.isna().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>author</th>\n",
       "      <th>title</th>\n",
       "      <th>subject</th>\n",
       "      <th>keywords</th>\n",
       "      <th>num_pages</th>\n",
       "      <th>text</th>\n",
       "      <th>is_relevant</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>ECDC</td>\n",
       "      <td>Effectiveness and cost-effectiveness of antena...</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>37</td>\n",
       "      <td>TECHNICAL  REPORT\\nEffectiveness and cost-  \\n...</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Unknown</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>45</td>\n",
       "      <td>SPECIAL REPORT\\nImplementing the  \\nDublin Dec...</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Unknown</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>15</td>\n",
       "      <td>SPECIAL REPORT\\nThematic report:  \\nSex worker...</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Unknown</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>36</td>\n",
       "      <td>TECHNICAL  REPORT\\nRisk assessment on HIV in G...</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>ECDC</td>\n",
       "      <td>Chlamydia - Annual epidemiological report</td>\n",
       "      <td>Chlamydia, surveillance, monitoring</td>\n",
       "      <td>Chlamydia, surveillance, monitoring</td>\n",
       "      <td>9</td>\n",
       "      <td>\\nSuggested citation: European Centre for Dis...</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>67</th>\n",
       "      <td>ECDC</td>\n",
       "      <td>Dublin Declaration evidence brief: HIV testing...</td>\n",
       "      <td>Dublin Declaration, HIV testing</td>\n",
       "      <td>HIV testing; Dublin Declaration; partnership t...</td>\n",
       "      <td>11</td>\n",
       "      <td>Suggested citation: HIV testing in Europe and ...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>68</th>\n",
       "      <td>Fabrice Donguy</td>\n",
       "      <td>AER_template.docx</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>8</td>\n",
       "      <td>\\n \\n \\nSuggested citation: European Centre f...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>69</th>\n",
       "      <td>Rumila Edward</td>\n",
       "      <td>2024-WCP-0017 Draft.docx</td>\n",
       "      <td>Not specified</td>\n",
       "      <td>Communicable disease threats report</td>\n",
       "      <td>13</td>\n",
       "      <td>\\n \\nEuropean Centre for Disease Prevention a...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>ECDC</td>\n",
       "      <td>Continuum of HIV care: 2022 progress report</td>\n",
       "      <td>HIV</td>\n",
       "      <td>HIV; continuum of HIV care; continuum of care;...</td>\n",
       "      <td>69</td>\n",
       "      <td>SPECIAL REPORT\\nContinuum of HIV care\\n \\nMoni...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>ECDC</td>\n",
       "      <td>Continuum of HIV care - Monitoring implementat...</td>\n",
       "      <td>HIV/AIDS, continuum of care</td>\n",
       "      <td>HIV/AIDS, continuum of care</td>\n",
       "      <td>59</td>\n",
       "      <td>SPECIAL REPORT\\nHIV Continuum of care\\nMonitor...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>72 rows × 7 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "            author                                              title  \\\n",
       "0             ECDC  Effectiveness and cost-effectiveness of antena...   \n",
       "1          Unknown                                            Unknown   \n",
       "2          Unknown                                            Unknown   \n",
       "3          Unknown                                            Unknown   \n",
       "4             ECDC         Chlamydia - Annual epidemiological report    \n",
       "..             ...                                                ...   \n",
       "67            ECDC  Dublin Declaration evidence brief: HIV testing...   \n",
       "68  Fabrice Donguy                                  AER_template.docx   \n",
       "69   Rumila Edward                           2024-WCP-0017 Draft.docx   \n",
       "70            ECDC        Continuum of HIV care: 2022 progress report   \n",
       "71            ECDC  Continuum of HIV care - Monitoring implementat...   \n",
       "\n",
       "                                 subject  \\\n",
       "0                                Unknown   \n",
       "1                                Unknown   \n",
       "2                                Unknown   \n",
       "3                                Unknown   \n",
       "4   Chlamydia, surveillance, monitoring    \n",
       "..                                   ...   \n",
       "67       Dublin Declaration, HIV testing   \n",
       "68                               Unknown   \n",
       "69                         Not specified   \n",
       "70                                   HIV   \n",
       "71           HIV/AIDS, continuum of care   \n",
       "\n",
       "                                             keywords  num_pages  \\\n",
       "0                                             Unknown         37   \n",
       "1                                             Unknown         45   \n",
       "2                                             Unknown         15   \n",
       "3                                             Unknown         36   \n",
       "4                 Chlamydia, surveillance, monitoring          9   \n",
       "..                                                ...        ...   \n",
       "67  HIV testing; Dublin Declaration; partnership t...         11   \n",
       "68                                            Unknown          8   \n",
       "69                Communicable disease threats report         13   \n",
       "70  HIV; continuum of HIV care; continuum of care;...         69   \n",
       "71                        HIV/AIDS, continuum of care         59   \n",
       "\n",
       "                                                 text  is_relevant  \n",
       "0   TECHNICAL  REPORT\\nEffectiveness and cost-  \\n...            0  \n",
       "1   SPECIAL REPORT\\nImplementing the  \\nDublin Dec...            0  \n",
       "2   SPECIAL REPORT\\nThematic report:  \\nSex worker...            0  \n",
       "3   TECHNICAL  REPORT\\nRisk assessment on HIV in G...            0  \n",
       "4    \\nSuggested citation: European Centre for Dis...            0  \n",
       "..                                                ...          ...  \n",
       "67  Suggested citation: HIV testing in Europe and ...            1  \n",
       "68   \\n \\n \\nSuggested citation: European Centre f...            1  \n",
       "69   \\n \\nEuropean Centre for Disease Prevention a...            1  \n",
       "70  SPECIAL REPORT\\nContinuum of HIV care\\n \\nMoni...            1  \n",
       "71  SPECIAL REPORT\\nHIV Continuum of care\\nMonitor...            1  \n",
       "\n",
       "[72 rows x 7 columns]"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "harvest_nlp"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Preprocessing/Cleaning"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "STOPWORDS = stopwords.words('english')\n",
    "lemmatizer = WordNetLemmatizer()\n",
    "\n",
    "def clean_text(text):\n",
    "\n",
    "    text = text.lower()\n",
    "\n",
    "    patterns = {\n",
    "        ### UNDERSTAND CONTEXT FIRST BEFORE CHANGING, HELPS TO MAKE MORE INFORMED DECISIONS\n",
    "        #remove \\n and \\r and \\t\n",
    "        r'\\n|\\r|\\t': ' ',\n",
    "\n",
    "        #replaces 4-digit numbers starting with 1 or 2 with \"year\"\n",
    "        r'\\b[12]\\d{3}\\b':'year',\n",
    "        \n",
    "        }\n",
    "    for pattern, replacement in patterns.items():\n",
    "        text = re.sub(pattern, replacement, text)\n",
    "\n",
    "    # remove punctuations\n",
    "    puncs = '''!()-[]{};:'\"\\,<>./?@#$%^&*_~'''\n",
    "    for p in puncs:\n",
    "        text = text.replace(p,'') \n",
    "    \n",
    "    # remove stopwords and make sure word length is greater than 1\n",
    "    text = [word.lower() for word in text.split() if word.lower() not in STOPWORDS and len(word)>1]\n",
    "\n",
    "    text = [lemmatizer.lemmatize(word) for word in text]\n",
    "\n",
    "    text = \" \".join(text) \n",
    "\n",
    "    return text\n",
    "\n",
    "harvest_nlp['text_modified'] = harvest_nlp['text'].apply(lambda x: clean_text(x))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "from collections import Counter\n",
    "\n",
    "all_text = ''.join(harvest_nlp['text_modified'])\n",
    "all_text_tokenized = [word for word in all_text.split()]\n",
    "word_counts = Counter(all_text_tokenized)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'technical report effectiveness cost effectiveness antenatal screening hiv hepatitis syphilis rubella susceptibility literature review wwwecdceuropaeu ecdc technical report effectiveness cost effectiveness antenatal screening hiv hepatitis syphilis rubella susceptibility literature review ii report commissioned european centre disease prevention control ecdc coordinated otilia mårdh tarik derrough andrew amato gauci report produced contract ecdc2012052 national institute health welfare hl carita savolainen kopra mia kontio marjukka mäkelä kirsi liitsola jukka lindeman jaana isojärvi heljä marja surcel irja davidkin henrikki brummer korvenkontio eija hiltunen back hanna nohynek tuija leino markku kuusi mika salminen helena de carvalho gomes ana belen escriva acknowledged internal ecdc support suggested citation european centre disease prevention control effectiveness cost effectiveness antenatal screening hiv hepatitis syphilis rubella susceptibility stockholm ecdc 2017 stockholm march 2017 isbn 9789294980359 doi 10290051864 catalogue number tq0417185enn european centre disease prevention control 20 17 reproduction authorised provided source acknowledged technical report effectiveness cost effectiveness antenatal screening hiv hepatitis syphilis rubella susceptibility iii content abbreviation glossary vi executive summary background method result conclusion background review method 21 search strategy 211 cost effectiveness 212 effectiveness 22 study selection criterion procedure 221 cost effectiveness 222 effectiveness review result 31 result search finding 311 cost effectiveness 312 effectiveness 32 hiv 321 effectiveness national programme antenatal screening hiv 322 cost effectiveness antenatal screening hiv 10 33 hepatitis 12 331 effectiveness antenatal screening hepatitis 12 332 cost effectiveness antenatal screening hepatitis 13 34 syphilis 15 341 effectiven es antenatal screening syphilis 15 342 cost effectiveness antenatal syphilis screening 16 35 rubella susceptibility 17 351 effectiveness antenatal screening rubella susceptibility 17 352 cost effectiveness antenatal screening rubella susceptibility 18 36 risk bias qualitystrength evidence 18 discussion 21 conclusion 22 next step 22 reference 23 appendix literature search topic cost effectiveness antenatal screening 26 appendix literature search topic effectiveness antenatal screening 28 effectiveness cost effectiveness antenatal screening hiv hepatitis syphilis rubella susceptibility technical report iv figure figure literature search topic economic evaluation screening hiv hepatitis syphilis rubella susceptibility including reason exclusion figure literature search topic effectiveness antenatal screening hiv supplemented citation found ancestry search citation analysis figure literature search topic effectiveness antenatal screening hepatitis supplemented citation found ancestry search citation analy si figure literature search topic effectiveness antenatal screening syphilis supplemented citation found ancestry search citation analysis figure literature search topic effectiveness antenatal scree ning rubella susceptibility supplemented citation found ancestry search citation analysis table table economic assessment hiv screening pregnancy 11 table economic assessment hepatitis screening pregnancy 14 table economic assessment syphilis screening pregnancy 17 table economi assessment rubella screening susceptibility pregnancy 18 table quality assessment selected publication based drummond criterion economic evaluation 19 technical report effectiveness cost effectiveness antenatal screening hiv hepatitis syphilis rubella susceptibility abbreviation aid acquired immunodeficiency syndrome an antenatal screening cba cost benefit analysis cea cost effectiveness analy si cr congenital rubella syndrome cua cost utility analysis daly disability adjusted life year hbeag hepatitis envelope antigen hbsag hepatitis surface antigen hbv hepatitis virus hiv human immunodeficiency virus icer incremental costeffectiveness ratio lyg life year gained lys life year saved mtct mother tochild transmission nns number needed screen pico patient intervention comparative outcome time qaly quality adjusted life year effectiveness cost effectiveness antenatal screening hiv hepatitis yphilis rubella susceptibility technical report vi glossary antenatal screening testing pregnant woman detect condition may threaten health foetus child antenatal screening programme national regional programme diagnostic testing pregnant woman detect certain condition programme clearly sta te aim objective include data collection evaluate result regularly audit entire programme effectiveness antenatal screening ability antenatal screening reduce prevent infection pregnancy could potentiall lead mother tochild transmission case rubella susceptible mother identified effectiveness antenatal screening prevention extended factor influencing implementation measure prevent infection child vertical ie mother tochild transmission stage pregnancy infancy andor breastfeeding operational effectiveness provides information well intended programmatic measure eg screening intervention implemented term coverage specificity quality necessary follow regard targeted population infant child le 12 month age migrant document term ‘migrant’ used widest sense embrace number population group mentioned literature mother tochild transmission transmission infectious agent mother child birth labour delivery infancy first year life also referred vertical transmission mandatory screening systematic testing population level without real possibility declining test test taken condition gain access care benefit service form application dividual right ie travel schooling day care employment etc declining screening test may lead sanction restriction individual civil right newborn child le one month age neonatal relating affecting newb orn infant first month birth diagnostic testing test order identify health condition individual administered explicit intention clinically managing condition optin testing individual seeking ca informed testing recommended individual required give explicit consent test performed optout testing testing performed part routine care pre test information made available consent assumed unle s individual explicitly decline testing rubella susceptibility lack protective antibody rubella virus protective antibody result natural infection vaccination universal screening testing systematically offered entire relevant population mandatory voluntary cover opt opt testing prenatal birth relating pregnancy synonym antenatal recommendation suggestion proposal authoritative body technical report effectiveness cost effectiveness antenatal screening hiv hepatitis syphilis rubella susceptibility vii screening systematic applic ation test examination procedure context report testing hiv hepatitis syphilis infection susceptibility rubella infection intention identifying previously unrecognised health condition population level relevant population dependent condition identified intended intervention must defined selective screening testing systematically offered entire relevant population mandatory voluntary cove r opt optout testing universal screening entire relevant population systematically offered testing mandatory voluntary cover opt opt testing voluntary screening testing systematically offered entire rel evant population whereby refusal lead immediate negative consequence restriction civil right sanction individual belonging population vulnerable population purpose guidance subpopulation group increased risk contracting hiv hbv syphilis rubella pregnancy already infected hard reach antenatal screening programme technical report effectiveness cost effectiveness antenatal screening hiv hepatitis syphilis rubella susceptibility executive summary background literature review effectiveness cost effectiveness antenatal screening conducted part project evaluat ing effectiveness antenatal screening an hiv hepatitis syphilis rubella susceptibility eueea member state purpose review provide evidence guidance strengthen antenatal screening programme europe method effectiveness antenatal screening defined factor influenc population completeness regard detection infection pregnancy factor could potentially lead mother child transmission mtct case rubella refers identification susceptible mother cost effectiveness an defined defining costeffectiveness preventive intervention many way value judgement acceptable co per prevented outcomegained life year adjusted unadjusted depend comparative valuation different disease economic situation country funding intervention research question formulated include following element based pico element population pregnant woman unborn child intervention national programme universal screening comparator screening screening high risk group outcome avoided infecti ons child cost per infection avoided time factor maternal screening confirmation child’s infection status database search performed 13 october 2011 12 march 2014 covered eueea country usa canada australia new zealand search language english danish finnish german norwegian swedish literature screened two independent researcher study selected based agreed inclusion criterion study quality wa assessed accordance criterion described guyatt et al effectiveness drummond et al economic evaluation result literature eview effectiveness antenatal screening hiv hepatitis syphilis rubella susceptibility retrieved nine study cost effectiveness 37 study effectiveness included analysis effectiveness antenatal screening depends coverage screening program quality testing effectiveness treatment ability reach pregnant woman sensitivity screening test ie capacity identify infected woman preventive treatment received infected pregnant woman factor ensure optimal effectiveness following ational antenatal screening programme considered cost effective comparison screening screening targeted risk group syphilis norway united kingdom hiv netherlands australia new zealand hepatitis united kingdom belgium rubella susceptibility netherlands especially targeted non vaccinated pregnant woman review also showed small number costeffectiveness study conducted europe conclusion hiv hepatitis syphilis study suggest comprehensive population based antenatal screening cost effective al assessed setting ffectiveness antenatal screening programme widely studied europe available literature mainly provide author opinion regarding factor influenc effectiveness comparative study effectiveness implementing antenatal screening programme found cost effective several country effectiveness cost effectiveness antenatal scre ening hiv hepatitis syphilis rubella susceptibility technical report background 2011 ecdc initiated project evaluate effectiveness antenatal screening programme hiv hepatitis syphilis rubella susceptibility eueea project included survey eueea member state obtain information current practice antenatal screening infectious disease order describe country specific approach iden tify area need improvement model good practice literature review published literature effectiveness cost effectiveness antenatal screening aim systematic literature review collect published ev idence effectiveness cost effectiveness antenatal screening practice prevention mother tochild transmission mtct hiv hepatitis syphilis rubella eueea country order inform ecdc guidance antenatal sc reening eueea review method 21 search strategy information specialist conducted systematic literature search cost effectiveness effectiveness screening programme target ed infection pregnancy appendi ce search strategy developed experienced information specialist collaboration content expert basis research question pico population intervention comparison outcome retrieve relevant study combina tion medical heading keywords used search title abstract result combined exclude duplicate review developed senior information specialist content expert 211 cost effectiveness research question national programme universal antenatal screening hiv hepatitis syphilis rubella susceptibility cost effective following pico element identified cost effectiveness review population pregnant woman unborn child intervention national universal screening programme pregnant woman syphilis hiv hepatitis rubella susceptibility therapeutic intervention positive test result rubella susceptibility vaccination prevent mtct future pregnancy comparator reference intervention screening screening high risk group outcome avoided infection child cost per infection avoided time factor maternal screening sample co nfirmation child infection status discussion expert decided life year gained lyg life year saved lys incremental costeffectiveness ratio icer also outcome interest outcome term used search addition would effect search reference included article checked relevant new article ancestry search october 2011 comprehensive search economic evaluation screening programme syphilis hiv hepatitis carried following database starting publication year 1990 ovid medline ovid medline daily update ovid medline proces non indexed citation nlm pubmed epubs ahead print centre review dissemination cochrane database systematic review cochrane central register controlled trial information concerning cost effectiveness wa derived systematic literature review economic evaluation antenatal screening syphilis hiv hepatitis commissioned finnish institute health welfare october 2011 updated october 2012 review economic evaluation rubella susceptibility screening carried using similar strategy october 2012 search updated january 2014 search strategy result presented appendix grey literature included 212 effectiveness research question national programme universal antenatal screening hiv hepatitis syphilis rubella susceptibility effective factor influencing effectiveness search strategy based costeffectiveness search term cost’ synonym used search term time period searched ranged 2000 present selected database technical report effectiveness cost effectiveness antenatal screening hiv hepatitis syphilis rubella susceptibility cost effectiveness search described hiv search limited eueea country usa canada australia new zealand second search an effectiveness conducted march 2014 ovid medline ensure important study missed previous search limited publication reporting cost screening programme search strategy result presented appendix grey literature included literature review cost effectiveness based following pico element population pregnant woman unborn child intervention national universal screening programme pregnant woman syphilis hiv hepatitis rubella susceptibility therapeutic intervention positive test result rubella susceptibility vaccination prevent mtct future pregnancy comparison screening screening high risk group outcome avoided infection child 22 study selection criterion procedure search targeted cost effectiveness effectiveness screening aim finding relevant evaluation antenatal screening program me article describing solely sensitivity specificity different test used screening included usually provide enough information test performance real world setting used data high quality screening program evaluation assessed using criterion drummond et al cost effectiveness study guyatt et al effectiveness study exclusion criterion cost effectiveness search cost information incorrect infection intervention eg prevalence study intervention line current practice description comparison laboratory method diagnostics language english danish finnish german norwegian swedish reason exclusion wrong study design health service utilisation treatment ethical legal issue sociodemographic issue attitude prognosis education exclusion criterion effectiveness search publication type without original data editorial letter etc country eu usa canada australia new zealand national data regional one city etc population pregnant woman intervention eg prevalence study intervention line current practice description comparison laboratory method diagnostics language english danish finnish german norwegian swedish eg treatment case description 221 cost effectiveness two researcher independently evaluated title abstract retrieved article selected potentially relevant article based agreed exclusion criterion differing choice discussed doubtful case included second round researcher evaluated fulltext version potentially relevant publication using detailed inclusion criterion given osts include scre ening cost well counselling treatment cost addition article mention infection child disease specific selection criterion clarified discussion infection expert syphilis testing treatment completed early pregnancy case hiv highly active antiretroviral therapy initiated later 28 week gestation final selection included publication made consensus order find cost benefi analysis eference sbibliographies selected article search ed material published search date two researcher independently assessed tudy quality drummond checklist economic evaluation disagreement resolved third researcher effectiveness cost effectiveness antenatal scre ening hiv hepatitis syphilis rubella susceptibility technical report 222 effectiveness evaluation procedure publication effectiveness identical one publication cost effectiveness two researcher screen ed title abstract evaluate study quality accordance criterion described guyatt et al became evident controlled study available descriptive result selected technical report effectiveness cost effectiveness antenatal screening hiv hepatitis syphilis rubella susceptibility review result 31 result search finding 311 cost effectiveness systemat ic literature search topic economic evaluation screening programme syphilis hiv hepatitis october 2011 identified 212 reference october 2012 search updated new article meeting inclusion criterion fo und search topic economic evaluation rubella susceptibility screening programme october 2012 identified 136 reference january 2014 update literature search topic economic evaluation screening programme identified 28 new article none met inclusion criterion figure literature search topic economic evaluation screening hiv hepatitis syphilis rubella susceptibility including reason exclusion search topic osteffectiveness screening programme hiv hepatitis syphilis effectiveness cost effectiveness antenatal scre ening hiv hepatitis syphilis rubella susceptibility technical report search topic cost effectiveness screening programme rubella susceptibility 312 effectiveness literature search topic effectiveness antenatal screening hiv hepatitis syphilis rubella susceptibility march 2014 retrieved 261 title hiv 140 hepatitis 160 syphilis 72 rubella susceptibility total 19 study hiv six hbv five syphilis seven rubella susceptibility met inclusion criterion figure literature search topic effectiveness antenatal screening hiv supplemented citation found ancestry search citation analysis technical report effectiveness cost effectiveness antenatal screening hiv hepatitis syphilis rubella susceptibility figure literature search topic effectiveness antenatal screening hepatitis supplemented citation found ancestry search citation analysis figure literature search topic effectiveness antenatal sc reening syphilis supplemented citation found ancestry search citation analysis effectiveness cost effectiveness antenatal scre ening hiv hepatitis syphilis rubella susceptibility technical report figure literature search topic effectiveness antenatal screening rubella susceptibility supplemented citation found ancestry search citation analysis 32 hiv 321 effectiveness national programme antenatal screening hiv search identify comparative study effectiveness antenatal screening hiv eight non comparative study 12 analysed effectiveness antenatal hiv screening study showed awareness hiv infection status crucial prevention mtct reported mtct case mainly associated mother’s un diagnosed hiv infection study emphasised importance antenatal screening prevention mtct high proportion pregnant woman recogn ised hiv infected prenatal testing region number neonatal hiv infection decrease woman high hiv risk tested hiv negative early pregnancy hiv test part routine check warrant ed repeated testing late pregnancy inclusion antenatal care provision prevention therapy mentioned important pregnant woman tested positive sweden population based analysis data known mother –child pair erinatal exposure hiv 1982–2003 conducted national screening program offering hiv testing woman regardless risk factor ethnic origin place since 1987 achieved high acceptance rate screening combined mtct prevention measure ie antiretroviral treatment elective caesarean delive ry resulted significant decrease number infected child mtct rate decreased 247 1985 –1993 57 1994 –1998 06 1999 –2003 child infected mother received two antiretroviral drug retrospective study hiv infected woman child born denmark january 2000 may 2005 showed 21 woman know hiv status beginning pregnancy eight child born hiv born mother whose hiv infection undiagnosed pregnancy delivery netherlands effectiveness antenatal hiv screening evaluated comparing result database antenatal screening data pregnant woman newborn data source 40 hiv infected woman diagnosed pregnancy 2004 netherlands introduced universal hiv screening opt prior introduction screening scheme 5–10 child ren hiv born technical report effectiveness cost effectiveness antenatal screening hiv hepatitis syphilis rubella susceptibility every year number dropped one child per year average introduction hiv screening known case mtct woman received antiretroviral therapy alberta canada retrospective analysi performed hiv infected pregnant woman delivered january 1999 february 2006 43 hiv infected pregnant woman unaware hiv status prior prenatal screening one 111 infant born hiv positive mother hiv nfected mother seek prenatal care u significant reduction perinatal hiv infection achieved routine hiv screening pregnant woman mtct prevention measure 1991 estimated 650 perinatal infec tions reported 2002 number 144 236 2001 u center disease control prevention recommended routine second hiv test third trimester woman elevated risk hiv infection region showed increasing proportion mtct woman tested hiv negative earlier pregnancy new york state outcome mtct prevention scheme 1988–2008 assessed based surveillance laboratory programme monitoring data 1997 half woman received prenatal testing since 2002 least 95 pregnant woman tested rate mtct declined significantly period time 115 1997 rsus 13 2008 mtct likely infant mother diagnosed hiv delivery whose mother diagnosed earlier infant whose mother receive prenatal care 10 u data hiv exposed singlet delivery 1996 –2000 used study missed opportunity perinatal hiv prevention two major missed opportunity observed lack prenatal care lack prenatal hiv diagnosis despite prenatal care 11 study north carolina conducted november 2002 april 2005 hiv rna testing used woman antibody negative time outine testing order determine prevalence acute antibody negative hiv infection pregnant woman total 02 woman tested positive 34 acute hiv infection one third woman acute hiv infection pregnant study period six hivinfected infant reported three born woman antibody negative 12 18 week gestation 12 eight study 13 23 compared performance several antenatal hiv screening strategiespolicies relation achieved coverage screening programme generally universal testing approach opt strategy considered effective however region achieve high testing rate among pregnant woman using opt strategy denmark effectiveness selective hiv screening fo prevention mtct studied 1997 recommended woman high risk group offered hiv testing pregnancy 2000 –2001 three infant born mother high risk group vertically infected none mother offered hiv test pregnancy concluded selective screening hiv pregnancy ineffective replaced universal offer hiv testing 19 dutch study compared two antenatal hiv screening strategy nonselective opt selective opt hiv infected pregnant woman retrospectively identified dutch hiv cohort 2000 –2008 data hivpositive infant identified questionnaire distributed paediatric hiv centre 2004 selective opt antenatal hiv screening strategy replaced non selective opt strategy opt screening combination prevention intervention appeared detect hiv infection pregnant woman reduce mtct substantially 2004 33 hivinfected pregnant woman diagnosed january 2004 80 diagnosed hiv infected child born hiv infected woman whose infection known pregnancy firsttrimester screenin 13 study conducted uk analysed effectiveness universal antenatal screening reach hiv infected pregnant woman universal antenatal screening introduced england 1999 scotland region policy universal testing 2003 mid 2003 remaining region implemented testing data demonstrated universal offering improved detection rate england scotland england estimated 12 woman remained undiagnosed deli 2003 compared 26 2000 scotland 11 woman remained undiagnosed delivery 2004 compared 32 2000 scottish data revealed increasing proportion woman infection diagnosed antenatally 17 catalonia spain policy universal offer hiv testing pregnant woman implemented since 1996 medical record showed hiv testing uptake rate 883 2000 94 public 71 private hospital study data show prenatal hiv testing frequently documented medical record 10 woman unaware tested 72 woman reported hiv testing information found medical record main reason ot hiv test offered test 65 20 study conducted u canada compared three different prenatal hiv antibody testing approach optin opt voluntary testing pregnant woman mandatory newborn testing newborn tested effectiveness cost effectiveness antenatal scre ening hiv hepatitis syphilis rubella susceptibility technical report 10 hiv without mother’s consent mother ’s hiv status unknown delivery testing rate among woman gave birth varied depending approach opt voluntary testing ndatory testing newborn associated highest testing rate region using optin approach testing rate varied 25 81 region using optout policy reported rate 71 98 shifting opt app roach either opt mandatory newborn testing increased prenatal hiv testing rate 14 california 1996 law mandate prenatal care provider offer hiv test pregnant woman data population based surveillance 496 hiv infected woman infant collected 1987 2002 analysed compare change iv test offer 1996 unsurprisingly significant increase hiv test offer period 1996−2002 1987 1995 532 woman giving birth offered hiv test 1996 2002 rate climbed 842 969 woman unknown hiv status accepted hiv test 23 study conducted ontario canada remis et al showed implementing policy offer hiv counselling testing pregnant woman 1999 increased testing rate 33 1999 96 2010 policy recom mended optin approach hiv testing carried pre test counsel ling informed consent 22 canadian province alberta us optout strategy prenatal hiv screening 2002–2004 serum sample woman opted serologically tested hiv proportion specimen woman opted ut prenatal hiv testing low decreased 43 2002 36 2004 hiv seroprevalence among specimen woman opted however 33 time higher hiv seroprevalence among specimen woman opted st udy period 21 canadian study dorval et al among woman attending antenatal care clinic 2005 recruited prior first antenatal appointment focused knowledge attitude regarding hiv antenatal hiv screening influence scree ning rate woman 92 supported universal hiv screening prenatal period 72 agreed optout policy 24 preferred opt woman accepting prenatal hiv screening likely aware benefit screening reduc mtct rate 15 french study jasseron et al investigated whether mtct management rate differed african immigrant french born hiv type infected woman gave birth france 1984 –2007 proportion african mother among hiv type infected pregnancy increased 118 1984 –1986 454 1996 1998 640 2002 –2004 higher percentage african woman 406 discovered infection pregnancy french born mother 115 76 afr ican woman started antiretroviral therapy 32 week gestation versus 41 french born pregnant woman late treatment initiation associated late access hiv diagnosis prenatal care overall mtct rate among mother receiving antiretroviral therapy pregnancy 15 1997 –2004 rate higher african 18 french born woman 08 18 data collected italy floridia et al 2001 –2006 also indicated foreign born woman le likely aware hiv infected pregnancy 876 versus 521 also start antiretroviral treatment later week 14 versus week woman italian nationality seven case mtct observed rate 19 two case nonitalian woman included one woman diagnosed delivery one woman diagnosed delivery five case italian woman included four woman received treatment ntiretroviral drug pregnancy one woman receiv ed intra partum tre atment 16 author pointed need specific intervention increase counselling hiv testing rate foreign woman become pregnant 322 cost effectiveness antenatal screening hiv three cost effectiveness anal y 2000s identified table osteffectiveness universal antenatal screening depends directly prevalence hiv infection 2008 study universal screening amsterdam netherlands considered costeffective prevalence equal higher 14 case per 100 000 population 24 australia prevalence cost effectiveness needed 437 case per 100 000 population reach osteffectiveness 25 study new zealand cited willingness policy maker pay additional life year gained influence decision regard universal selective screening 26 dutch study mentioned universal screening hiv infection pregnancy compared offering screening 24 analysis done healthcare perspective study estimated life year gained lyg avoiding infection child well cost associated screening lifetime medical cost hiv infected child study found systematic screening cost effective compared screening based willingness topay threshold value 20 000 eurlyg prevalence hiv infected pregnant woman least 14 case per 100 000 population author concluded universal hiv screening pregnancy amsterdam justified generate significant net cost saving health benefit situation technical report effectiveness cost effectiveness antenatal screening hiv hepatitis syphilis rubella susceptibility 11 2004 australia study universal hiv scree ning pregnancy compared thencurrent practice testing pregnant woman explicitly asked tested considered high risk 25 costeffectiveness systematic screening assessed looking likelihood hiv infection among screened study estimated additional life year gained mother child cost associated screening lifetime medical cost hiv infected child value one additional year life defined average income per caput multiplied two also taken account cost earlier initiation treatment infected mother child training cost healthcare personnel universal hiv screening stimated cost effective australia prevalence hiv infection among unscreened population 00016 00106 author concluded universal screening would cost effective low prevalence would generate measurable benefit also highlighted need accurate statistic prevalence analysis healthcare point view compared universal hiv screening pregnant woman new zealand screening based risk assessment 26 analysis treatment cost mother child included ‘for defined period birth point assumed mother baby would identified regardless universal screening programme 26 additional life year gained infected mother earlier initiation treatment also taken account result analysis compared favourably cost estimate per life year gained simi lar study developed country well healthcare intervention new zealand main factor affecting decision whether implement universal screening program me new zealand hiv prevalence addition policy makers’ willingness pay additional life year gained table economic assessment hiv screening pregnancy publication country comparator type analysis perspective time factor cohort prevalence test assumption finding hiv rozenbaum et al 2008 amsterdam netherlands 24 screening cost effectiveness analysis healthcare children’s lifespan oneyear cohort 10 000 pregnancy prevalence 93 cases100 000 population combined sensitivity specificity screening confirmatory test 100 universal screening found 93 maternal infection yearly 93100 000 number needed screen 075 prevented infection 24 child total cost screening program eur 376 408 eur 156 837one child’s infection avoided lifetime medical cost hiv infected child eur 179 974 sensitivity analysis incremental cost effectiveness ratio screening v screening became positive number new hiv case decreased le 69100 000 willingness pay threshold eur 20 000lyg screening remained cost effective even low incidence new case 14100 000 graf et al 2004 australia 25 current practice test conducted increased risk identified mother want tested cost effectiveness analysis quasi societal perspective lifetime oneyear cohort 250 000 delivery analysed different prevalence assumption among unscreened 67 combined sensitivity specificity screening confirmatory test 100 universal screening prevailing practice cost effective prevalence hiv case among unscreened least 437100 000 niversal screening det ect additional 695 maternal infection per year prevent 173 infection child child would gain 4697 additional year life lyg costlyg aud 39 000 eur 29 000 higher prevalence screening achieved net benefit effectiveness cost effectiveness antenatal scre ening hiv hepatitis syphilis rubella susceptibility technical report 12 publication country comparator type analysis perspective time factor cohort prevalence test assumption finding hiv bramley et al 2003 new zealand 26 screening based risk mapping cost effectiveness analysis healthcare lifetime oneyear cohort 56 000 pregnancy prevalence 30 100 000 universal screening found 1425 maternal infection per year 254100 000 number needed screen 930 prevented 115 infection child meant 4197 life year gained lyg screening based risk mapping found maternal infection yearly prevented 065 infection child 1998 lyg incremental costeffectiveness ratio universal screening versus screening based risk mapping usd 267 944 eur 198 300one child’s infection avoided usd 7336 eur 400 eurlyg quasi societal perspective author included cost benefit state funded healthcare sector dded valuation life year gained reflects preference individual community 33 hepatitis 331 effectiveness antenatal screening hepatitis search identify comparative study effectiveness antenatal screening hepatitis total six article found dealt effectiveness hepatitis screening three article contained effectiven es data effectiveness antenatal screening prevention hepatitis vertical transmission shown depend prevalence infection level maternal viral load among pregnant woman well coverage screeni ng programme effectiveness antenatal screening prevention perinatally transmitted hbv infection assessed six italian region 2001 shown 95 newborn hbsag positive mother given active passive mmunisation newborn foreign mother received active passive immunisation introduction compulsory antenatal hbsag screening pregnant woman led vastly improved screening adherence three factor observed predict lack compliance screening large family size birth private hospital immigration developing country pregnant woman foreign country high hbsag carrier rate shown two time le likely adhere hbsag screening th italian woman supplementary effort suggested improve effectiveness programme among foreign born woman 27 another italian study evaluated compliance protocol prevention perinatal hepatitis infection public private hospital 13 italian region 2008 2009 prevalence hbsag among pregnant woman varied 04 italian born woman 344 woman born astern europe overall prevalence 086 nearly 98 pregnant woman screened 100 newborn hbsag positive mother received immunoprophylaxis birth giving birth public hospital hospital located southern italy foreign nationality predic tor screened 28 denmark selective screening missed 30 –50 pregnant woman high risk group opt screening introduc ed 2005 led vaccination coverage 96 among newborn hbsag positive mother twice high prevalence hepatitis study 0012 among woman danish origin 274 among foreign born woman general screening prevented 84 case mother tochild transmission among newborn mother carried hepatitis virus 29 study ireland found uptake hepatitis screening excellent 9998 woman presenting antenatal care accepted hepatitis screening screening revealed 87 case hbv carrier status previously unk nown cost screening equated gbp 013 per new diagnosis considered highly cost effective considering morbidity mortality associated vertically transmitted hepatitis selective screening would missed significan number infected opt screening concluded appropriate selective screening added advantage equitable easy implement 30 greece reason complying universal prenatal testing hbsag studied concern woman higher disease burden may escape screening universal mass vaccination combined improvement socioeconomic sanitary co nditions well screening blood donor led technical report effectiveness cost effectiveness antenatal screening hiv hepatitis syphilis rubella susceptibility 13 significant decrease hbv prevalence large influx immigrant led shift epidemiology immigrant woman compris ing almost 20 child bearing population greece overall screening rate 913 nationwide study hospital athens serving large population refugee reported rate 894 pregnant woman escaped hepatitis screening likely chronically infected deliver public hosp ital classified illiterate immigrant concluded stepped surveillance immunisation programme better access routine screening needed effectively prevent mtct among immigrant mother 31 norway classified low prevalence country hepatitis infection prevalence hepatitis pregnant woman 01 vaccination targeted primarily risk group national guideline recommend screening immigrant high prevalence country particu larly asylum seeker also child adopted abroad data regarding uptake testing vaccination among population limited percentage mother tochild transmission registered route transmission shown 02 concluded universal screening introduced universal vaccination strategy considered given high cost reaching target population author also recommend surveillance system hepatitis evaluated addition screening effectiveness assessed immigrant population receive vaccination 32 since 1989 netherlands screened pregnant woman hbsag first visit obstetrician midwife gp study amsterdam hepatitis prevalence higher rest netherlands found increase 91 97 antena tal screening coverage 1993 –1998 rate hbsag positivity lowest 007 among pregnant woman netherlands antilles low 007 among native dutch woman highest 89 among woman ghana amsterdam enhanced screening rogramme considered cheap effective used monitor impact neonatal immuni sation programme included analysis sample public health laboratory informed municipal health service hbsag positive mother needed confirmatory testing xpected delivery date recorded computer ised system public health nurse made sure hepatitis immune globulin hbig available within week public health nurse verified hbig given arranged first dose vaccine administered home hospital second dose vaccine administered municipal health service site 33 sugges ted contact tracing vaccination contact hbsag positive woman integrated hepatitis antenatal screening programme encouraging result reducing pool infective individual among older child adult 34 2008 antenatal hbsag prevalence netherlands 033 992 hbsag positive woman long term carrier ost frequently reported region origin asia 38 sub saharan africa 23 due antenatal scr eening estimated number 50 75 hbv infection newborn could prevented annually 332 cost effectiveness antenatal screening hepatitis literature search identified hree cost effectiveness analysis 1990s hepati ti screening table two study uk healthcare perspective prevalence rang ed 0083 13 study compared universal screening pregnant woman screening based risk mapping 3536 concluded costeffectiveness universal screening acceptable level recommended screening introduced tudies highlighted limiting screening high risk group would lea number maternal infection undetected lead infection child important assumption affected result sensitivity analysis infection prevalence cost screening test likelihood transmission study belgian healthcare perspective com pared universal screening screening revalence time study 067 37 cost effectiveness universal screening comparable generally accepted medical procedure screening pregnant woman vaccinati ng neonate risk considered cost saving main assumption influencing result sensitivity analysis prevalence infection screening vaccination cost discount rate effectiveness cost effectiveness antenatal scre ening hiv hepatitis syphilis rubella susceptibility technical report 14 table economic assessment hepatitis screening pregnancy publication country comparator type analysis perspective time factor cohort prevalence test assumption finding hepatitis jordan law 1997 uk 35 screening based identified high risk cost effectiveness analysis healthcare lifetime cohort size 100 000 hbsag+ entire population 152100 000 highrisk population 500–3000100 000 proportion hbeag positive people entire population 21 high risk population 17– 40 sensitivity specificity screening test 100 universal screening found 152 carrier mother cohort 100 000 number needed screen 000 prevents 34 newborn infection death child due hepatoma chronic liver disease four child infected spite systematic screening universal screening program cost gbp 150 000 gbp 4412 eur 300one child’s infection avoided gbp 500 eur 000lys screened every pregnancy gbp 78 000 gbp 294 eur 750 eurone child infection avoided gbp 300 eur 560lys screened first pregnancy screening based identified high risk identified 102 carrier mother preventing 24 infection child 43 death 14 child infected cost gbp 330 eur 400 eurlys screened first pregnancy dwyer mcintyre 1996 east anglia uk 36 screening based identified risk current practice cost effectiveness analysis healthcare lifetime one year cohort approximately 26 500 pregnancy hbsag+ 83100 000 hbeag positive 22 sensitivity screening test 100 specificity prior confirmatory test 995 universal screening found 22 carrier mother per year 44 childr en screening based identified risk found carrier mother 32 prevented infection 18 child universal screening prevented 26 infection 08 death child saving 21 life year lys compared current practice direct cost universal screening gbp 51 560 gbp 11 718 eur 14 000one child infection avoided incremental cost lys gbp 437 eur 912 tormans et al 1993 belgium 37 screening cost effectiveness analysis healthcare lifetime cohort size 100 000 hbsag+ 670100 000 hbeag positive 20 universal screening found 670 carrier mother prevented 175 infection child saved 427 life year lys per 100 000 pregnant woman screened despite screening 26 child infected without screening 201 child would infected saving medical cost 175 avoided infection bef 013 129 screening program total cost bef 31 719 490 bef 181 254 usd 850one child’s infection avoided net cost society 24 918 903 bef 142 394 bef 593 usdone child’s infection avoided bef 583 581 usd 18 825lys technical report effectiveness cost effectiveness antenatal screening hiv hepatitis syphilis rubella susceptibility 15 34 syphilis 341 effectiveness antenatal screening syphilis literature search identify comparative study effectiveness antenatal screening syphilis five article reporting effectiveness syphilis screening identified five article include search screening proved reduce adverse pregnancy outcome ie stillbirth perinatal death although woman country specific high risk group found affected higher rate syphilis pregnancy universal antenatal screening policy considered effective ethically appropriate 2006 study united kingdom cited three major risk factor infectious syphilis pregnant woman included living london south east belonging et hnic minority group born abroad antenatal screening performed routine ly national data number case syphilis diagnosed pregnancy also lacking data rate congenital syphilis stu dy called robust national surveillance syphilis pregnan woman identification recording case congenital syphilis 38 united state syphilis found common nonwhite woman 30 year age little education low income woman syphilis likely late prenatal care woman high risk high prevalence area recommended screened second time third trimester 39 austrian study ocument ed development syphilis analyse effectiveness antenatal syphilis screening practice austria austria ncidence syphilis declined geographical variation large metropolitan vienna incidence 12 time higher federal province mainly rural character cost screening rural area four time higher potential saving calculation suggest ed universal syphilis screening pregnancy justified author recommended consideration given replace general screening targeted screening highrisk group 40 2011 systematic review literature three outcome assessed examine evidence effectiveness intervention increased uptake syphilis testing increased treatment rate reduction adverse pregnancy outcome ten study intervention improve outcome antenatal syphilis screening included study allow assessment ideal time syphilis screening included study provide sufficient information outcome partner treatment also lacking sufficient information repeat screening third trimester reduce risk reinfection delayed treatment syphilis pregnancy increased likelihood congenital syphilis screening found reduce adverse pregnancy outcome particularly rate stillbirth perinatal death 41 switzerland antenatal screening syphilis generally recommended discontinued 1990s notifiability syphilis infection restored 1999 due increasing incidence rate 2006 2009 infectious syphil case woman childbearing age increase substantially improvement prenatal care syphilis programme ware recommended 42 analysis global regional estimate syphilis pregnancy adverse outcome performed 2008 data syphilis seropositivity among antenatal care attendee europe reported 016 analysis included country data reported hiv universal access system available recommended countri e collect data least three indicator mtct syphilis proportion antenatal care attendee tested syphilis proportion seropositive attendee proportion seropositives adequately treated conclude country scale screening treatment syphilis pregnancy 43 1999 compulsory notification syphilis came end netherlands since nationwide registration system monitor ing congenital syphilis acceptance syphilis screening test high test refused one four time year congenital syphilis diagnosed fewer five newborn per year case mother belonged vulnerable group illegal immigrant drug user estimated 10 case syphilis newborn prevented screening universal screening considered simpler acceptable programme focused risk group prospective alian study 2006 –2007 found maternal syphilis seroprevalence delivery 017 seropositive mother born outside italy foreign origin associated worse neonatal outcome congenital syphilis diagnosed 201 00 000 live birth maternal risk factor included young age 20 antenatal care adequate treatment author observe association marital status unemployment previous syphilis diagnosis coexistence maternal infection majority infant born seropositive mother delivered northern italian hospital immigrant mother mostly eastern europe total 25 itali mother antenatal syphilis screening versus 12 immigrant woman 44 effectiveness cost effectiveness antenatal scre ening hiv hepatitis syphilis rubella susceptibility technical report 16 uk study late 1990s switching target ed surveillance even stopping antenatal screening syphilis observed save relatively little money three group pregnant woman identified potentia target group pregnant woman thames region woman belonging nonwhite ethnic group woman born outside united kingdom selective screening country birth ethnic group would etect least 70 case targeting region would also effective 30 case would still missed addition selective screening would cause ethical medico legal problem politically practically difficult medico legal cost could associated failure prevent miscarriage stillbirth illness resulting congenital infection missed case targeted screening run risk missing newly developing risk group unexpected increase transmission 45 article without primary data author advocated priority listing scaling control sexually transmitted infection hivaids strengthening artner notification also considered necessary wo uld improve case finding would prevent infection existing partner could interrupt onward transmission sexual network 46 342 cost effectiveness antenatal syphilis screening two cost effectiveness analysis identified syphilis review table literature search economic evaluation syphilis screening retrieved cost effectiveness analysis healthcare perspective late 1990 united kingdom 45 cost–benefit analysis using societal point view early 1980s norway 47 table recommended syphilis screening early pregnancy continued uk study 45 compared systematic screening syphilis early pre gnancy limited screening option consequence infection transmission child impact life expectancy treatment cost estimated study found direct cost limited screening option lower 70 77 infected mother would identified ie several child would infected year limiting screening would also bring ethical legal practical political problem reason due changing international syphilis prevalence recommended systematic screening pregnancy implemented norwegian study 47 systematic screening syphilis early pregnancy compared screening screening estimated ave rt cost caused infection child ie treatment special education residential care loss earnings achieved cost saving almost four time higher cost incurred yearly screening program continuation screening recommended study modelling cost cost effectiveness screening treatment syphilis pregnancy published report almost finalised modelled screening eight generic country scenario conclude congenital syphilis could eliminated expanded screening treatment program antenatal care facility would cost saving high prevalence setting prevalence reactive syphilis serological test pregnancy low prevalence scenario cost per daly disability adjusted life year averted ranged usd 24 usd 111 author conclude according standard would cost effective 48 technical report effectiveness cost effectiveness antenatal screening hiv hepatitis syphilis rubella susceptibility 17 table economic ass sment syphilis screening pregnancy publication country comparator type analysis perspective time factor cohort prevalence test assumption finding syphilis connor et al 2000 uk 45 limited screening option geographical area screening different risk group cost effectiveness analysis healthcare one year one year cohort 750 000 pregnancy prevalence systematic screening 6100 000 limited group 18 62 100 000 combined sensitivity specificity screening confirmatory test 100 systematic screening found 403 maternal infection yearly number needed screen 18 602 prevented 135 infection newborn cost gbp 49 928 eur 59 900one child’s infection avoided restricted screening option found 283 –31 maternal infection prevented 89 –98 infection child cost gbp 958 –20 976 eur 10 749– eur 25 170one child’s infection avoided incremental costeffectiveness ratio systematic screening versus limited screening option gbp 109 588–gbp 153 461 eur 131 500– eur 184 150one child’s infection avoided straypedersen 1983 norway 47 screening cba societal children’s lifespan one year cohort 50 000 pregnancy prevalence 20100 000 combined sensitivity screening confirmatory test 100 combined specificity 996 systematic screening found 10 maternal infection annually 20100 000 number needed screen 000 prevented six infection child 50 000 pregnancy cost program usd 230 000 usd 38 300 eur 28 800 eurone child’s infection avoided economic value benefit achieved screening avoiding institutional care special education loss income usd 877 920 benefit cost ratio 38 35 rubella susceptibility 351 effectiveness antenatal screening rubella susceptibility literature search identify comparative study effectiveness antenatal screening rubella susceptibility however seven descriptive study concerning effectiveness rubella susceptibility screening identified country high vaccination coverage low rubella incidence antenatal screening rubella susceptibility discontinued however subnational area risk group remain antenatal screening rubella susceptibility still considered necess ary 49 three uk study ass ed effectiveness rubella susceptibility screening study london high screening rate 90 rubella susceptibility found overall rubella susceptibility 36 however london susceptibility rate considerably higher 143 understood reflect ethnic diversity area 50 study conducted national health service nh blood transplant large number sample antenatal woman screened routine check nh study identified two predictor low level rubella antibody birth cohort born 1990 ethnicity 51 significant increase low leve l rubella antibody 10iuml observed another uk study changing pattern rubella seronegativity susceptibility pregnant woman born 1983 observed found difficult obtain accurate figure uptake postpartum immun isation rate requirement notify adult measles mumps rubella mmr vaccination recording authority 52 ireland researcher concluded order prevent congenital rubella syndrome cr heal th service focus woman young nulliparous born outside eu increased rate rubella seronegativity general population 2009 associated increase migration study also found would cost effective focus screening easily identifiable group also vaccination without serological testing woman country without rubella programme could cost effective 53 effectiveness cost effectiveness antenatal scre ening hiv hepatitis syphilis rubella susceptibility technical report 18 canadian study quebec inhospital postpartum vaccinat ion found effective mean vaccinating group risk misconception vaccine use noted affected timely administration led missed opportunity 54 italy free serological testing rubella susceptibility een part standard pregnancy care since 1995 study congenital infection campania region found ystematic process outcome monitoring implemented standard care unequal possibly excluding low income pregnant wo men poor antenatal care dramatic rise congenital rubella rubella incidence pregnancy 2008 might consequence vaccination campaign child 2004 –2007 carried without conducting catch campaign vaccinate susceptible woman childbearing age congenital rubella found issue since one case found native born mother action reduce gap child adult vaccination coverage recommended 55 goal national program eradicate measles congenital rubella pnem italy reduce limit occurrence cr le one case per 100 000 live birth fewer five case per year reach 95 vacc ination coverage paediatric age le pregnant woman susceptible rubella proportion woman found risk rubella infection 142 highest risk rate found woman 15 –25yearold group 247 338 susceptible woman pregnant least vaccination recommended performed discharge high proportion woman observed unaware risk posed rubella infection pregnancy 36 56 352 cost effectiveness antenatal screening rubella susceptibility one cost effectiveness analysis rubella susceptibility screening identified literature search table dutch cost utility analysis 2010 49 compared creening non vaccinated pregnant woman low vaccination coverage region lvr screening pregnant woman lvr screening non vaccinated pregnant woman country calculation based 2004 –2005 rubella epidemic netherlands cost calculated separately epidemic non epidemic year screening pregnant woman rubella antibody found cost effective targeted unvaccinated woman lvr netherlands screening pregnant woman lvr screening non vaccinated pregnant woman netherlands costeffective cost saving due avoided treatment cost prevented complication lifelong table economic assessment rubella screening susceptibility pre gnancy publication country comparator type analysis perspective time factor cohort prevalence test assumption finding rubella lugner et al 2010 netherlands 49 screening based vaccination status costutility analysis healthcare lifetime screening time frame 16 year 2004–2005 outbreak pregnant woman rubella inf ection 32 case congenital rubella syndrome 11 case annual expected cost screening non vaccinated pregnant woman lvr eur 17 900 screening pregnant woman lvr eur 107 800 screening non vaccinated pregnant woman eur 266 600 preventing complication rubella infection pregnancy lead average 229 qalys gained screening va ccination programme lifelong scenario would cost effectiveness ratio eur 26 900 eur 28 100qaly gained 16 year period would cost effective targeted non vaccinated woman lvr eur 100qaly gained note cost utility analysis focused three scenario screening non vaccinated pregnant woman low vaccination coverage region lvr screening pregnant woman lvr screening non vaccinated pregnant woman netherlan d including pregnant first generation non western immigrant woman 36 risk bias qualitystrength evidence included study effectiveness antenatal screening hiv hepatitis syphilis rubella susceptibility general descriptive include comparison group thus judged low quality technical report effectiveness cost effectiveness antenatal screening hiv hepatitis syphilis rubella susceptibility 19 three study cost effectiveness hiv screening 24 26 high quality table fulfilled 24 910 25 810 26 10 criterion program costeffectiveness study see drummond jefferson description comparator ordinary described full detail two latter study 2425 bramley et al 26 reported capital cost program omission judged impact validity conclusion costeffectiveness study creening hepatitis 35 37 high quality fulfilling least 10 drummond criterion table none study discussed general isability regard setting presented incremental analysis one 37 use discounting presenting effect omission judged impact validity conclusion two cost effectiveness study 4548 fulfilled drummond criterion thus high quality table stray pedersen 47 failed conduct incremental sensitivity analysis conclusion based calculated net benefit rather cost –effectiveness ratio quality study still considered high cost –utility study rubella suscept ibility screening fulfilled drummond criterion table table quality assessment selected publication based drummond criterion economic evaluation hiv hepatitis syphilis rubella quality assessment included program costeffectiveness study drummond criterion rosenbaum et al 2008 graf et al 2004 bramley et al 2003 jordan law 1997 dwyer mcintyre 1996 tormans et al 1993 connor et al 2000 straypedersen 1983 lugner et al 2009 welldefined question posed answerable form yes yes yes yes yes yes yes yes yes 11 study examine cost effect service programme yes yes yes yes yes yes yes yes yes 12 study involve comparison alternative yes yes yes yes yes yes 13 viewpoint analysis stated study placed particular decision making context yes yes yes yes yes yes yes yes yes comprehensive description competing alternative given ie tell often yes yes yes yes yes yes yes 21 important alternative omitted yes yes yes yes yes 22 nothing alternative considered yes yes yes effectiveness programme service established yes yes yes yes yes yes yes yes yes 31 done randomised controlled clinical trial 32 effectiveness established overview clinical study yes yes yes yes yes yes yes yes yes 33 observational data assumption used establish effectiveness yes yes yes yes yes important relevant cost consequence alternative identified yes yes yes yes yes yes yes yes 41 range wide enough research question hand yes yes yes yes yes yes yes 42 cover relevant viewpoint yes yes yes 43 capital cost well operating cost included yes yes yes yes cost consequence measured accurately appropriate physical unit yes yes yes yes yes yes yes yes yes 51 identified item omitted measurement yes 52 special circumstance made measurement difficult handled appropriately yes cost consequence valued credibly yes yes yes yes yes yes yes yes yes 61 source value clearly identified yes yes yes yes yes yes yes yes yes 62 market value employed change involving resource gained depleted yes yes yes yes yes yes yes yes yes 63 market value absent reflect actual value adjustment made approximate market value 64 valuation consequence appropriate question posed yes yes yes yes yes yes yes yes yes cost consequence adjusted differential timing yes yes yes yes yes yes 71 cost consequence occur future ‘discounted’ present value yes yes yes yes yes 72 justification given discount rate used yes effectiveness cost effectiveness antenatal scre ening hiv hepatitis syphilis rubella susceptibility technical report 20 hiv hepatitis syphilis rubella quality assessment included program costeffectiveness study drummond criterion rosenbaum et al 2008 graf et al 2004 bramley et al 2003 jordan law 1997 dwyer mcintyre 1996 tormans et al 1993 connor et al 2000 straypedersen 1983 lugner et al 2009 incremental analysis cost consequence alternative performed yes yes yes yes yes 81 additional incremental cost generated one alternative another compared additional effect benefit utility generated yes yes yes yes yes allowance made uncertainty estimate cost consequence yes yes yes yes yes yes yes yes 91 data cost consequence stochastic appropriate statistical analysis performed yes yes yes yes yes yes yes yes 92 sensitivity analysis employed justification provided range value yes yes yes yes 93 study result sensitive change value yes yes yes yes yes yes yes 10 presentation discussion study result include issue concern user yes yes yes yes yes 101 conclusion analysis based overall index ratio cost consequence eg cost effectiveness ratio yes yes yes yes yes yes 102 result compared others investigated question yes yes yes yes yes yes 103 study discus generalisability result setting patient group yes yes yes 104 study allude take account important factor choice decision consideration yes yes yes yes yes 105 study dis cuss issue implementation whether freed resource could redeployed programme yes yes yes yes yes technical report effectiveness cost effectiveness antenatal screening hiv hepatitis syphilis rubella susceptibility 21 discussion effectiveness antenatal screening target infection depends primarily coverage screening program quality testing effectiveness treatment addition factor cost effectiveness influenced prevalence infection among pregnant woman cost screening program practicepolicy screening compared program cost depend mainly cost administering analysing screening confirmatory test type healthcare personnel time cost medication necessary treatment patient compliance coverage compliance un iversal screening policy enhanced increasing level awareness public information enhancing provider awareness improved access testing treatment follow allocation adequate resource 55 screening usually provided early stage pregnancy second screening late pregnancy highly unlikely cost effective especially country relatively low incidence hiv hbv syphilis general universal screening con sidered simpler acceptable programme focuse risk group 41 limitation literature review effectiveness cost effectiveness antenatal screening limited publication english nordic language overa linguistic bias low 29 981 identified publication excluded language restriction reference document language preserved yet translated source material project potential future use literature review cost effectiveness antenatal screening found relatively relevant article three hiv three hepatitis two syphilis one rubella susceptibility emphas i fact antenatal screening infectious disease rarely assessed cost effectiveness evidence based manner also show need assessment existing practice scope literature search broadened autho r report felt making recommendation based nine article data collected survey inadequate allowed review costindependent factor effectiveness operational level expanded search resul ted inclusion 19 additional article hiv six hepatitis five syphilis seven rubella susceptibility screening provided helpful background information development future guidance document literature review depend quality search strategy ability identify relevant article address question review screening search result relevance always involves degree subjectiv ity even performed accordance predefined inclusion criterion selection article followed predefined step always carried two person initially worked independently several search strategy tested various database final search strategy decided upon additional significant publication could retrieved modification algorithm particularly difficult project comprehensively identify grey literature report type public ations indexed database even published english one nordic language ancestry search used identify material although approach provide additional publication likely relevant material may missed effectiveness cost effectiveness antenatal scre ening hiv hepatitis syphilis rubella susceptibility technical report 22 conclusion regard hiv hepatitis syphilis study suggest comprehensive population based antenatal screening cost effective european setting researched end judgement cost effectiveness value judgement judging whether preventive programme cost effective highly dependent threshold set cost per life year health metric used saved unless sho wn programme actually saving cost figure describes much invested programintervention per year every life year saved vary country depending multiple factor cannot determined authority national policymakers every country need prioritise health investment accordance national need considered ‘t olerable cost varies widely europe somewhere thousand hundred thousand euro per life year saved addition comparison cost cost effectiveness threshold notoriously difficult country system impossible due heterogen eity healthcare system diff erent approach employed antenatal screening infection effectiveness antenatal screening depends coverage screening program quality testing effectiveness treatment ability reach pregnant woman sensitivity screening test ie capacity identify infected woman preventi treatment received infected pregnant woman factor influence effectiveness order ass performance effectiveness antenatal screening infection essential comprehensive surveillance system place accurate ly record prevention failure ie transmission hiv hepatitis syphilis rubella moth er child document target indicator screening programme ideally surveillance system record information infected mother child attempt identify risk factor mtct document mtct rate identify target indicator point toward opportunity improvement antenatal screening care next step result literature review serve basis ecdc guidance document strengthening antenatal screening programme eueea member state technical report effectiveness cost effectiveness antenatal screening hiv hepatitis syphilis rubella susceptibility 23 reference guyatt rennie o’meade dj user guide medical literature manual evidence based clinical practice 2nd edition ed chicago american medical association 2008 drummond mf sculphe mj torrance gw critical assessment economic evaluation drummond mf sculpher mj torrance gw obrien bj stoddart gl editor method economic evaluation healthcare programme 3rd ed oxford oxford university press 2005 european centre disease prevention control antenatal screening hiv hepatitis syphilis rubella susceptibility eueea stockholm ecdc 2016 surcel hm haula mäkelä aho hiltunen back salo et al screening infe ctions early pregnancy finland thl report 20147 naver lindgren belfrage gyllensten lidman gisslen et al child born hiv 1infected woman sweden 1982 2003 trend epidemiology vertical transmission acquir immune defic syndr 2006 aug 1424484 rasmussen mb rasmussen jb nielsen vr herlin fisker hornstrup mk et al prevention vertical transmission hiv denmark ugeskrift laeger 2008 aug 18170342567 70 op de coul el hahne van weert yw oomen smit van der ploeg kp et al antenatal screening hiv hepatitis syphilis netherlands effective bmc infect dis 201111185 hughes ca zuk foisy robinson singh ae houston prenatal screening perinatal hiv transmission northern alberta 1999 2006 public health 2009 oct99 suppl 2s412 center disease prevention achievement public health reduction perinatal transmission hiv infection united state 1985 2005 mmwr morb mortal wkly rep 2006 jun 25521592 10 birkhead g pulver wp warren bl klein sj parker mm caggana et al progress prevention mother tochild transmission hiv new york state 1988 2008 public health manag pract 2010 nov dec166481 91 11 peter liu kl dominguez frederick melville hsu hw et al missed opportunity perinatal hiv prevention among hiv exposed infant born 1996 2000 pediatric spectrum hiv disease cohort pediatrics 2003 may1115 pt 21186 91 12 patterson kb leone pa fiscus sa kuruc mccoy si wolf et al frequent detection acute hiv infection pregnant woman aid 2007 nov 1221172303 13 boer smit van der flier de wolf group ac comparison performance two screening strategy identifying newly diagnosed hiv pregnancy eur public health 2011 oct215632 14 center disease control prevention cdc hiv testing among pregnant woman united state canada 1998 2001 mmwr morb mortal wkly rep 2002 nov 1551451013 15 dorval ritchie gruslin screening hiv pregnancy survey prenatal care patient public health 2007 sep oct985379 82 2007 sep oct98 5379 82 16 floridia tamburrini bucceri tibaldi anzidei guaraldi et al pregnancy outcome antiretroviral treatment national cohort pregnant woman hiv overall rate difference according nationality bjog 2007 jul1147896 900 epub 2007 may 15 17 goldberg logan unlinked anonymous testing indicates antenatal hiv testing england scotland successfully implemented euro surveill 2005 may 19105e0505194 18 jasseron mandelbrot tubiana teglas jp faye dollfus et al prevention mother tochild hiv transmission similar access sub sahara african immigrant french woman aid 2008 jul 3122121503 11 19 nielsen vr valerius nh hiv screening pregnanc ytoo many failure ugeskrift laeger 2002 nov 18164475522 20 perez blanch casabona almeda coll cobemb coverage hiv testing among pregnant woman catalonia spain comparison self reporting medical record eur public health 2004 sep143261 21 plitt s singh ae lee preiksaitis jk hiv seroprevalence among woman opting prenatal hiv screening alberta canada 2002 2004 clin infect dis 2007 dec 1545121640 effectiveness cost effectiveness antenatal scre ening hiv hepatitis syphilis rubella susceptibility technical report 24 22 remis r merid mf palmer rw whittingham king sm danson n et al high uptake hiv testing pregnant woman ontario canada plo one 2012711e48077 23 sarnquist cc cunningham sd sullivan maldonado effectiveness state national policy implementation perinatal hiv prevention intervention public health 2007 jun9761041 24 rozenbaum mh verweel folkerts dk dronkers van den hoek ja hartwig ng et al cost effectiveness estimate antenatal hiv testing netherlands int std aid 2008 oct1910668 75 25 graf walker dg mcdonald kaldor jm ziegler jb would universal antenatal screening hiv infection cost effective setting low prevalence modelling data australia infect dis 2004 jul 11901166 74 26 bramley graf walker cost effectiveness universal antenatal screening hiv new zealand aid 2003 mar 28175741 27 stroffolini bianco szklo bernacchia bove colucci et al factor affecting compliance antenatal hepatitis screening programme italy vaccine 2003 mar 72111 121246 28 spada tosti zuccaro stroffolini mele collaborating study group evaluation compliance protocol preventing perinatal hepatitis infection italy infect 2011 feb622165 71 29 harder km cowan eriksen mb krarup hb christensen pb universal screening hepatitis among pregnant woman led 96 vaccination coverage among newborn hbsag positive mother denmark vaccine 2011 nov 2129509303 30 healy cm cafferkey mt butler km cahill mcmorrow philbin et al antenatal hepatitis screening need national policy ir med 2001 apr944111 114 31 karatapanis skorda marinopoulos papastergiou drogosi lisgos et al higher rate chronic hepatitis infection low vaccination induced protection rate among parturients escaping hbsag prenatal testing reece year prospective study eur gastroenterol hepatol 2012 aug248878 83 32 rimseliene nilsen klovstad blystad aavitsland epidemiology acute chronic hepatitis virus infection norway 1992 –2009 bmc infect dis 2011 11153 33 van steenbergen je leentvaar kuijpers baayen dukers ht van doornum gj van den hoek ja et al evaluation hepatitis antenatal screening neonatal immunization program amsterdam 1993 1998 vaccine 2001 oct 12201 2711 34 van steenbergen je baayen peerbooms pg coutinho ra van den hoek much gained integrating contact tracing vaccination hepatitis antenatal screening program amsterdam 1992 1999 hepatol 2004 jun406979 85 35 jordan law appraisal efficacy cost effectiveness antenatal screening hepatitis med screen 199743117 27 36 dwyer mj mcintyre pg ante natal screening hepatitis surface antigen appraisal value low prevalence area epidemiol infect 1996 aug1171121 31 37 tormans van damme carrin clara eylenbosch cost effectiveness analysis prenatal screening vaccination hepatitis virus case belgium soc sci med 1993 jul 372173 81 38 doroshenko sherrard pollard aj syphilis pregnancy neonatal period int std aid 2006 apr174221 quiz 228 39 carey jc congenital syphilis 21st century curr woman health rep 2003 aug34299 302 40 kiss widhalm geusau husslein universal antenatal screening syphilis still justified economically 10 year retrospective analysis eur obstet gynecol reprod biol 2004 jan 15112124 41 hawkes matin broutet low effectiveness intervention improve screening syphilis pregnancy systematic review meta analysis lancet infect dis 2011 sep119684 91 42 meyer sauteur pm truck bosshard pp tomaske moran cadenas lautenschlager et al congenital syphilis switzerland gone forgotten return swiss med wkly 2012 jan 11141w13325 43 newman kamb hawkes gomez say seuc et al global estimate syphilis pregnancy associated adverse outcome analysis multinational antenatal surveillance data plo med 2013102e1001396 technical report effectiveness cost effectiveness antenatal screening hiv hepatitis syphilis rubella susceptibility 25 44 tridapalli capretti mg reggiani ml stronati faldella italian neonatal task force congenital syphilis italian society neonatology collaborative grou congenital syphilis italy multicentre study arch dis child fetal neonatal ed 2012 may973f211 45 connor robert nicoll strategic option antenatal screening syphilis united kingdom cost effectiveness analysis med screen 2000717 13 46 low hawkes sj putting magic magic bullet top three global priority sexually transmitted infection control sex transm infect 20118744 47 straypedersen economic evaluation maternal screening prevent congenital syphilis sexually transmitted disease sex transm dis 1983 oct dec104167 72 48 kahn jg jiwani gomez gb hawkes sj chesson hw broutet et al cost cost effectiveness scaling screening treatment syp hilis pregnancy model plo one 201491e87510 49 lugner ak mollema ruijs wl hahne sj cost utility analysis antenatal screening prevent congenital rubella syndrome epidemiol infect 2010 aug13881172 84 50 anderson sr righar t maguire surveillance antenatal infection hiv hepatitis syphilis rubella susceptibility london commun dis public health 2004 dec74251 51 byrne brant reynolds ramsay seroprevalence low rubella igg antibody level among antenatal woman england tested nh blood transplant 2004 2009 rubella susceptibility increasing vaccine 2012 jan 5302161 52 matthew la lawrance lm gray gray audit rubella igg antibody status antenatal woman nh trust year 2005 2009 epidemiol infect 2011 nov139111720 53 odwyer bonham mulligan oconnor farah kennelly mm et al antenatal rubella immunity ireland ir med 2013 sep1068232 54 gyorkos tw tannenbaum tn abrahamowicz delage carsley marchand evaluation rubella screening pregnant woman cmaj 1998 nov 315991091 55 buffolano agnese pizzuti secular trend congenital infection insight campania region register perinatal infection southern italy matern fetal neonatal med 2011 oct24 suppl 194 56 calimeri capua la fauci squeri grillo oc lo giudice prevalence serum anti rubella virus antibody among pregnant woman south ern italy int gynaecol obstet 2012 mar1163211 effectiveness cost effectiveness antenatal scre ening hiv hepatitis syphilis rubella susceptibility technical report 26 appendix literature search topic costeffectiveness antenatal screening centre review dissemination syphilissh 72 hiv infectionssh 4759 hepatitis bsh 977 rubellash 87 rubella three day measles german measlestiabkw 280 htlv iii lav infection htlv iii infectionstiabkw 6041 mass screeningsh 3382 neonatal sc reeningsh 207 10 prenatal diagnosissh 256 11 10 3766 12 pregnancysh 14270 13 pregnancy complicationssh 826 14 12 13 14284 15 11 14 43 16 prenatal pre natal antenatal ante natal pregnan near2 screenaf 4106 17 16 141 18 15 17 149 19 economicsaf 2958 20 exp cost cost analysissh 18256 21 economics dental 22 exp economics hospital 1384 23 economics medical 32 24 economics nursing 14 25 economics pharmaceutical 211 26 economic cost cost costly costing price price pricing pharmacoeconomictiab 31504 27 expenditure energytiab 585 28 value moneytiab 57 29 budgettiab 271 30 19 20 21 22 23 24 25 26 27 28 29 31 energy oxygen adj costtiab 220 32 metabolic adj costtiab 49 33 energy oxygen adj expendituretiab 1519 34 31 32 33 1714 35 30 34 36090 36 letterpt 5231 37 editorialpt 301 38 historical articlept 69 39 36 37 38 5597 40 35 39 36020 41 animal 6983 42 human 407047 43 41 42 6978 44 41 43 45 40 44 36016 46 18 45 63 ovid med line ovid medline daily update exp syphilis 21555 exp hiv infection 215924 exp hepatitis 43196 exp rubella 7185 rubella three day measles german measlestiab 9912 htlv iii lav infection htlv iii infectionstiab 29 285293 exp mass screening 93878 exp prenatal diagnosis 57125 10 exp neonatal screening 6582 11 10 148860 12 exp pregnancy 680883 13 exp pregnancy complication 322016 14 12 13 713713 15 11 14 1698 16 prenatal pre natal antenatal ante natal pregnan adj2 diagnos screentiab 28314 17 16 965 18 15 17 2149 19 news comment letter editorial terviewpt 1319199 20 18 19 1882 21 exp economics 467445 22 quality adjusted life year 6054 23 exp model economic 9182 24 markov chain 8614 25 monte carlo method 18018 26 decision tree 8285 27 economictiab 12703 28 cost costing costly costedtiab 277671 29 price pricingtiab 20775 30 pharmacoeconomic pharmaco adj economictiab 2995 technical report effectiveness cost effectiveness antenatal screening hiv hepatitis syphilis rubella susceptibility 27 31 budgettiab 15968 32 expenditurestiab 9259 33 value adj1 money monetarytiab 299 34 fee feestiab 10796 35 health related quality lifetiab 17361 36 hrqoltiab 5607 37 quality adjusted life yeartiab 4682 38 qalytiab 4047 39 cbatiab 8429 40 ceatiab 15063 41 cuatiab 42 cost adj utilittiab 1980 43 markovtiab 10004 44 monte carlotiab 18537 45 decision adj2 tree analy modeltiab 9484 46 21 22 23 24 25 26 27 28 29 30 31 32 33 34 36 37 38 39 40 41 42 43 44 45 810427 47 news comment letter editorial interviewpt 1319199 48 46 47 733807 49 20 48 279 50 limit 49 yr=1990 current 239 ovid medline process non indexed citation ovid medline prenatal pre natal antenatal ante natal pregnan adj2 diagnos screentiabkw 30224 syphilis hiv hepatitis german measles three day measles rubella htlv iii lav infection htlv iii infectionstiabkw 286109 1111 cost–benefit cost effective econom qalytiabkw 229506 124 nlm pubmed epubs ahead print qaly qalys economic cost–benefit cost effective 686808 32 pubstatusaheadofprint 154787 11449 syphilis hiv hepatitis rubella german measles three day measles htlv iii lav fections htlv iii infection 354311 prenatal pre natal antenatal ante natal neonatal pregnan diagnosis screen 421869 effectiveness cost effectiveness antenatal scre ening hiv hepatitis syphilis rubella susceptibility technical report 28 appendix literature search topic effectiveness antenatal screening exp rubella 7306 exp syphilis 22141 exp hiv infection 228801 exp hepatitis 45197 exp mass screening 98703 exp prenatal diagnosis 59184 exp neonatal screening 7028 155662 exp pregnancy 702836 10 exp pregnancy complication 333484 11 10 736539 12 11 201 13 11 274 14 11 1084 15 11 268 16 prenatal pre natal antenatal ante natal pregnan adj2 diagnos screentiab 29450 17 16 115 18 16 208 19 16 491 20 16 222 21 12 17 246 22 13 18 372 23 14 19 1325 24 15 20 374 25 exp european union 11542 26 exp finland 27409 27 exp sweden 56357 28 exp norway 29293 29 exp denmark 36465 30 exp germany 123683 31 exp austria 15351 32 exp estonia 1781 33 exp lithuania 2039 34 exp latvia 966 35 exp poland 37190 36 exp hungary 15501 37 exp romania 7913 38 exp bulgaria 5828 39 exp greece 13530 40 exp malta 525 41 exp italy 68354 42 exp spain 52363 43 exp france 76523 44 exp great britain 297274 45 exp czech republic 4757 46 exp slovakia 1714 47 exp switzerland 27770 48 exp liechtenstein 27 49 exp new zealand 28702 50 exp australia 97387 51 exp united state 1087112 52 exp canada 118200 53 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 2149316 54 exp netherlands 48494 55 exp belgium 13605 56 53 54 55 2204280 57 21 56 66 58 22 56 105 59 23 56 591 60 24 56 173 61 limit 59 yr=2000 current 263 hiv without restriction country 62 limit 12 yr=2000 current 51 rubella 63 limit 13 yr=2000 current 151 syphilis 64 limit 15 yr=2000 current 99 hepb ecdc committed ensuring transparency independence work accordance staff regulation official condition employment servant european union ecdc independence policy ecdc staff member shall performance duty deal matter directly indirectly personal interest impair independence declaration interest must received prospective contractor contract awardedwwwecdceuropaeuenaboutustransparency obtain eu publication free publication one opy via ookshop httpbookshopeuropaeu han ne opy ostersmaps uropean nion’s presentation httpeceuropaeurepresentenhtm rom elegations oneu ountries httpeeaseuropaeudelegationsindexenhtm ontacting urope irect ervice httpeuropaeueuropedirectindexenhtm alling 00 800 10 11 freephone number anywhere eu nformation iven ree ost alls though ome perators hone ox otels ay harge ou priced publication via ookshop httpbookshopeuropaeueuropean centre disease prevention control ecdc postal address granits väg se171 65 solna swedenvisiting address tomtebodavägen 11 se171 65 solna sweden tel +46 858601000 fax +46 858601001 wwwecdceuropaeu agency european union wwweuropaeusubscribe monthly email wwwecdceuropaeuenpublications contact u publicationsecdceuropaeu follow u twitter ecdceu like facebook page wwwfacebookcomecdceu'"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "harvest_nlp['text_modified'][0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Counter({'hiv': 15977,\n",
       "         'country': 11649,\n",
       "         'data': 6679,\n",
       "         '00': 5573,\n",
       "         'report': 5099,\n",
       "         'reported': 4824,\n",
       "         'case': 4685,\n",
       "         'testing': 4402,\n",
       "         'among': 3946,\n",
       "         'sex': 3914,\n",
       "         'population': 3623,\n",
       "         'health': 3567,\n",
       "         'europe': 3551,\n",
       "         'migrant': 3534,\n",
       "         '10': 3378,\n",
       "         'european': 3349,\n",
       "         'number': 3320,\n",
       "         'men': 3303,\n",
       "         'infection': 3076,\n",
       "         'surveillance': 3074,\n",
       "         'total': 2955,\n",
       "         'people': 2851,\n",
       "         'prevention': 2833,\n",
       "         'aid': 2723,\n",
       "         '11': 2722,\n",
       "         '12': 2689,\n",
       "         'rate': 2566,\n",
       "         'reporting': 2564,\n",
       "         'centre': 2538,\n",
       "         '15': 2528,\n",
       "         'year': 2498,\n",
       "         'drug': 2488,\n",
       "         'national': 2463,\n",
       "         'eueea': 2407,\n",
       "         'treatment': 2398,\n",
       "         '2008': 2295,\n",
       "         'region': 2294,\n",
       "         '13': 2282,\n",
       "         'study': 2271,\n",
       "         'msm': 2249,\n",
       "         '14': 2192,\n",
       "         'diagnosis': 2169,\n",
       "         'care': 2168,\n",
       "         'source': 2144,\n",
       "         'woman': 2122,\n",
       "         'east': 2097,\n",
       "         '16': 2083,\n",
       "         '2010': 2069,\n",
       "         'risk': 2047,\n",
       "         'service': 2037,\n",
       "         'use': 2030,\n",
       "         'transmission': 2006,\n",
       "         '2007': 2006,\n",
       "         'programme': 1947,\n",
       "         'figure': 1946,\n",
       "         '25': 1873,\n",
       "         'group': 1845,\n",
       "         'west': 1813,\n",
       "         'available': 1810,\n",
       "         '20': 1764,\n",
       "         'table': 1760,\n",
       "         'diagnosed': 1736,\n",
       "         '100': 1736,\n",
       "         'screening': 1733,\n",
       "         'worker': 1732,\n",
       "         'hivaids': 1729,\n",
       "         '17': 1719,\n",
       "         '18': 1701,\n",
       "         '22': 1639,\n",
       "         '21': 1631,\n",
       "         '24': 1601,\n",
       "         'information': 1591,\n",
       "         '19': 1552,\n",
       "         'disease': 1540,\n",
       "         'ecdc': 1534,\n",
       "         '000': 1533,\n",
       "         'test': 1527,\n",
       "         'also': 1516,\n",
       "         'dublin': 1466,\n",
       "         '23': 1434,\n",
       "         '26': 1377,\n",
       "         '27': 1374,\n",
       "         'prevalence': 1363,\n",
       "         '2006': 1356,\n",
       "         'survey': 1312,\n",
       "         'new': 1306,\n",
       "         'prison': 1306,\n",
       "         '02': 1301,\n",
       "         'sexual': 1300,\n",
       "         'declaration': 1296,\n",
       "         'need': 1293,\n",
       "         'yes': 1293,\n",
       "         'indicator': 1267,\n",
       "         'asia': 1258,\n",
       "         'response': 1253,\n",
       "         'one': 1239,\n",
       "         '2009': 1239,\n",
       "         '28': 1217,\n",
       "         '2011': 1214,\n",
       "         'society': 1210,\n",
       "         'injecting': 1205,\n",
       "         '01': 1203,\n",
       "         '32': 1199,\n",
       "         'based': 1191,\n",
       "         'may': 1190,\n",
       "         'central': 1182,\n",
       "         '30': 1175,\n",
       "         'civil': 1174,\n",
       "         'republic': 1163,\n",
       "         'used': 1159,\n",
       "         'per': 1158,\n",
       "         '29': 1153,\n",
       "         'condom': 1151,\n",
       "         'united': 1148,\n",
       "         '03': 1139,\n",
       "         'eu': 1129,\n",
       "         'policy': 1096,\n",
       "         '04': 1089,\n",
       "         'spain': 1082,\n",
       "         'evidence': 1065,\n",
       "         '05': 1061,\n",
       "         '50': 1057,\n",
       "         'progress': 1056,\n",
       "         'living': 1051,\n",
       "         'level': 1049,\n",
       "         'france': 1042,\n",
       "         'high': 1041,\n",
       "         '31': 1036,\n",
       "         '35': 1030,\n",
       "         'al': 1030,\n",
       "         '33': 1028,\n",
       "         'antenatal': 1025,\n",
       "         'access': 1000,\n",
       "         'netherlands': 999,\n",
       "         'system': 999,\n",
       "         '2012': 991,\n",
       "         '34': 990,\n",
       "         'target': 988,\n",
       "         'greece': 986,\n",
       "         'public': 983,\n",
       "         '40': 982,\n",
       "         'ungass': 978,\n",
       "         'idu': 977,\n",
       "         'female': 964,\n",
       "         'germany': 962,\n",
       "         'community': 958,\n",
       "         'intervention': 951,\n",
       "         'sweden': 951,\n",
       "         'monitoring': 950,\n",
       "         'provided': 943,\n",
       "         'na': 939,\n",
       "         'time': 925,\n",
       "         'area': 925,\n",
       "         'including': 923,\n",
       "         '07': 921,\n",
       "         'increase': 917,\n",
       "         'estonia': 916,\n",
       "         'key': 912,\n",
       "         '36': 902,\n",
       "         '38': 902,\n",
       "         '2004': 897,\n",
       "         'result': 896,\n",
       "         'coverage': 893,\n",
       "         '2005': 887,\n",
       "         'et': 880,\n",
       "         'hepatitis': 877,\n",
       "         'see': 876,\n",
       "         'italy': 874,\n",
       "         'art': 874,\n",
       "         'epidemic': 870,\n",
       "         'however': 867,\n",
       "         'belgium': 866,\n",
       "         'partner': 865,\n",
       "         '37': 864,\n",
       "         'romania': 859,\n",
       "         'support': 856,\n",
       "         'heterosexual': 856,\n",
       "         '42': 851,\n",
       "         '08': 849,\n",
       "         'setting': 848,\n",
       "         'noneueea': 844,\n",
       "         'included': 842,\n",
       "         'general': 838,\n",
       "         'male': 832,\n",
       "         'sti': 828,\n",
       "         'technical': 825,\n",
       "         'last': 825,\n",
       "         'control': 816,\n",
       "         '41': 816,\n",
       "         'behaviour': 814,\n",
       "         'switzerland': 813,\n",
       "         'since': 812,\n",
       "         'ukraine': 812,\n",
       "         'kingdom': 808,\n",
       "         'uk': 805,\n",
       "         'latvia': 805,\n",
       "         'question': 800,\n",
       "         'proportion': 796,\n",
       "         '09': 792,\n",
       "         'government': 788,\n",
       "         '43': 787,\n",
       "         'behavioural': 787,\n",
       "         'continuum': 785,\n",
       "         'two': 784,\n",
       "         'age': 783,\n",
       "         'syphilis': 780,\n",
       "         'respondent': 780,\n",
       "         '06': 779,\n",
       "         'bulgaria': 778,\n",
       "         '48': 773,\n",
       "         'low': 769,\n",
       "         'norway': 768,\n",
       "         '45': 760,\n",
       "         'poland': 760,\n",
       "         '44': 759,\n",
       "         'ireland': 754,\n",
       "         'sample': 753,\n",
       "         'example': 753,\n",
       "         'plhiv': 750,\n",
       "         'lithuania': 746,\n",
       "         'portugal': 746,\n",
       "         '46': 743,\n",
       "         'effectiveness': 737,\n",
       "         '39': 737,\n",
       "         '49': 732,\n",
       "         'denmark': 729,\n",
       "         'contact': 721,\n",
       "         '2016': 720,\n",
       "         '53': 716,\n",
       "         'africa': 712,\n",
       "         'eg': 707,\n",
       "         'include': 701,\n",
       "         'finland': 696,\n",
       "         'strategy': 692,\n",
       "         'specific': 683,\n",
       "         'increased': 681,\n",
       "         'ethnic': 679,\n",
       "         'czech': 675,\n",
       "         'luxembourg': 675,\n",
       "         '51': 674,\n",
       "         'pwid': 673,\n",
       "         'different': 672,\n",
       "         'three': 670,\n",
       "         'cumulative': 670,\n",
       "         'review': 665,\n",
       "         'moldova': 663,\n",
       "         '47': 662,\n",
       "         '90': 662,\n",
       "         'mode': 654,\n",
       "         'provide': 653,\n",
       "         'month': 652,\n",
       "         'positive': 650,\n",
       "         'special': 645,\n",
       "         'serbia': 643,\n",
       "         'individual': 642,\n",
       "         '65': 642,\n",
       "         'percentage': 634,\n",
       "         '55': 634,\n",
       "         'de': 633,\n",
       "         'state': 632,\n",
       "         'hungary': 630,\n",
       "         'slovakia': 629,\n",
       "         'unaids': 629,\n",
       "         'unknown': 628,\n",
       "         'slovenia': 627,\n",
       "         'comment': 624,\n",
       "         'infected': 623,\n",
       "         '95': 623,\n",
       "         'many': 619,\n",
       "         '57': 619,\n",
       "         '52': 616,\n",
       "         'higher': 614,\n",
       "         'rubella': 613,\n",
       "         'stage': 611,\n",
       "         'le': 610,\n",
       "         'related': 610,\n",
       "         'issue': 609,\n",
       "         'status': 607,\n",
       "         'georgia': 607,\n",
       "         'patient': 604,\n",
       "         'cd4': 603,\n",
       "         'action': 602,\n",
       "         'social': 601,\n",
       "         'non': 599,\n",
       "         'origin': 596,\n",
       "         '60': 594,\n",
       "         'minority': 593,\n",
       "         'geographical': 593,\n",
       "         'questionnaire': 592,\n",
       "         'overall': 589,\n",
       "         'malta': 587,\n",
       "         'method': 581,\n",
       "         'annex': 581,\n",
       "         'cost': 574,\n",
       "         'counselling': 574,\n",
       "         'research': 572,\n",
       "         'user': 569,\n",
       "         'iceland': 567,\n",
       "         'croatia': 566,\n",
       "         'kazakhstan': 558,\n",
       "         'communication': 556,\n",
       "         'tested': 554,\n",
       "         'estimated': 552,\n",
       "         'within': 552,\n",
       "         'america': 551,\n",
       "         'four': 550,\n",
       "         'international': 550,\n",
       "         '1000': 550,\n",
       "         'azerbaijan': 548,\n",
       "         'clinic': 545,\n",
       "         'late': 544,\n",
       "         'size': 544,\n",
       "         'north': 543,\n",
       "         'person': 543,\n",
       "         'effective': 540,\n",
       "         'austria': 538,\n",
       "         'migration': 538,\n",
       "         '54': 537,\n",
       "         'discrimination': 536,\n",
       "         'global': 533,\n",
       "         'emcdda': 533,\n",
       "         'due': 531,\n",
       "         '58': 531,\n",
       "         '62': 530,\n",
       "         'prisoner': 529,\n",
       "         'kyrgyzstan': 529,\n",
       "         '56': 528,\n",
       "         '85': 528,\n",
       "         'uzbekistan': 528,\n",
       "         'armenia': 528,\n",
       "         'regional': 527,\n",
       "         'inject': 524,\n",
       "         '59': 523,\n",
       "         'knowledge': 522,\n",
       "         'part': 521,\n",
       "         '77': 518,\n",
       "         'cyprus': 516,\n",
       "         'healthcare': 513,\n",
       "         'approach': 509,\n",
       "         '75': 509,\n",
       "         'tajikistan': 509,\n",
       "         'co': 508,\n",
       "         '66': 508,\n",
       "         'implementation': 507,\n",
       "         '2014': 503,\n",
       "         'member': 500,\n",
       "         'trend': 500,\n",
       "         '80': 499,\n",
       "         '67': 499,\n",
       "         'using': 498,\n",
       "         '61': 497,\n",
       "         '63': 497,\n",
       "         'important': 494,\n",
       "         'type': 494,\n",
       "         '78': 493,\n",
       "         'th': 491,\n",
       "         '64': 487,\n",
       "         'belarus': 487,\n",
       "         'therapy': 485,\n",
       "         'russia': 484,\n",
       "         'would': 483,\n",
       "         '71': 482,\n",
       "         'macedonia': 480,\n",
       "         'israel': 477,\n",
       "         'uptake': 476,\n",
       "         '72': 473,\n",
       "         'count': 473,\n",
       "         '2013': 472,\n",
       "         'child': 471,\n",
       "         '68': 468,\n",
       "         'first': 465,\n",
       "         'although': 465,\n",
       "         'work': 465,\n",
       "         'bosnia': 465,\n",
       "         'newly': 464,\n",
       "         'found': 463,\n",
       "         '83': 462,\n",
       "         'african': 461,\n",
       "         'stigma': 461,\n",
       "         '73': 458,\n",
       "         'range': 457,\n",
       "         'albania': 457,\n",
       "         'herzegovina': 455,\n",
       "         'pregnant': 454,\n",
       "         'project': 454,\n",
       "         'barrier': 454,\n",
       "         '2022': 454,\n",
       "         '76': 449,\n",
       "         '93': 449,\n",
       "         'analysis': 445,\n",
       "         'young': 443,\n",
       "         'euefta': 443,\n",
       "         'virally': 443,\n",
       "         'finding': 442,\n",
       "         'mothertochild': 441,\n",
       "         'practice': 440,\n",
       "         '86': 440,\n",
       "         '91': 439,\n",
       "         'stockholm': 437,\n",
       "         'well': 437,\n",
       "         '81': 436,\n",
       "         '82': 436,\n",
       "         'identified': 434,\n",
       "         '94': 434,\n",
       "         'activity': 433,\n",
       "         '84': 432,\n",
       "         '70': 426,\n",
       "         '88': 424,\n",
       "         '92': 423,\n",
       "         'suppressed': 423,\n",
       "         'compared': 422,\n",
       "         '87': 422,\n",
       "         'turkey': 420,\n",
       "         '2015': 420,\n",
       "         'viral': 419,\n",
       "         'implementing': 413,\n",
       "         'needle': 413,\n",
       "         'particularly': 412,\n",
       "         'montenegro': 412,\n",
       "         'antiretroviral': 409,\n",
       "         '74': 409,\n",
       "         'factor': 408,\n",
       "         'law': 408,\n",
       "         'yugoslav': 408,\n",
       "         'reduction': 407,\n",
       "         'former': 406,\n",
       "         '69': 404,\n",
       "         'period': 403,\n",
       "         'funding': 402,\n",
       "         'could': 401,\n",
       "         '2003': 400,\n",
       "         'current': 399,\n",
       "         'estimate': 398,\n",
       "         'pregnancy': 397,\n",
       "         'organisation': 395,\n",
       "         'particular': 394,\n",
       "         'relevant': 391,\n",
       "         'virus': 390,\n",
       "         'guidance': 387,\n",
       "         '89': 385,\n",
       "         'vulnerable': 384,\n",
       "         'subsaharan': 384,\n",
       "         'mother': 383,\n",
       "         'collection': 382,\n",
       "         'series': 382,\n",
       "         'san': 382,\n",
       "         'recipient': 380,\n",
       "         '96': 378,\n",
       "         'million': 378,\n",
       "         'active': 376,\n",
       "         '98': 373,\n",
       "         'quality': 371,\n",
       "         'south': 371,\n",
       "         'ministry': 368,\n",
       "         'presented': 367,\n",
       "         'across': 367,\n",
       "         'following': 365,\n",
       "         'five': 365,\n",
       "         'affected': 364,\n",
       "         'human': 363,\n",
       "         'evaluation': 362,\n",
       "         'ngo': 362,\n",
       "         'several': 360,\n",
       "         'commission': 360,\n",
       "         '2000': 359,\n",
       "         'sub': 359,\n",
       "         '79': 357,\n",
       "         'message': 355,\n",
       "         'likely': 354,\n",
       "         'blood': 351,\n",
       "         'measure': 350,\n",
       "         'conducted': 350,\n",
       "         'london': 350,\n",
       "         'cohort': 349,\n",
       "         'hbv': 348,\n",
       "         'right': 348,\n",
       "         'significant': 347,\n",
       "         'change': 347,\n",
       "         'plan': 346,\n",
       "         'guideline': 344,\n",
       "         'marino': 344,\n",
       "         'turkmenistan': 344,\n",
       "         'tb': 343,\n",
       "         'recent': 343,\n",
       "         'outcome': 341,\n",
       "         'definition': 341,\n",
       "         'provision': 340,\n",
       "         'lack': 339,\n",
       "         'addition': 339,\n",
       "         'process': 339,\n",
       "         'medical': 337,\n",
       "         'increasing': 337,\n",
       "         'transmitted': 337,\n",
       "         'epidemiology': 337,\n",
       "         '2021': 337,\n",
       "         'limited': 333,\n",
       "         '97': 333,\n",
       "         'office': 333,\n",
       "         'fund': 332,\n",
       "         'andorra': 332,\n",
       "         'universal': 331,\n",
       "         'union': 331,\n",
       "         'infectious': 330,\n",
       "         'aged': 330,\n",
       "         '102': 329,\n",
       "         'generalised': 329,\n",
       "         'caribbean': 329,\n",
       "         'partnership': 328,\n",
       "         'sexually': 326,\n",
       "         'otherundetermined': 326,\n",
       "         'six': 322,\n",
       "         'impact': 322,\n",
       "         'able': 322,\n",
       "         'latin': 322,\n",
       "         '200': 321,\n",
       "         'nosocomial': 320,\n",
       "         'attitude': 319,\n",
       "         'assessment': 318,\n",
       "         'provider': 318,\n",
       "         'monaco': 318,\n",
       "         '103': 317,\n",
       "         'main': 316,\n",
       "         'born': 315,\n",
       "         'term': 312,\n",
       "         'interview': 312,\n",
       "         'syrinx': 311,\n",
       "         'scale': 310,\n",
       "         '101': 309,\n",
       "         'rapid': 309,\n",
       "         'effort': 307,\n",
       "         'institute': 306,\n",
       "         'considered': 305,\n",
       "         'meeting': 305,\n",
       "         'asked': 304,\n",
       "         'round': 301,\n",
       "         'education': 300,\n",
       "         'kosovo': 300,\n",
       "         'improve': 299,\n",
       "         'focus': 299,\n",
       "         'section': 299,\n",
       "         'epidemiological': 298,\n",
       "         'receiving': 297,\n",
       "         'box': 297,\n",
       "         'place': 296,\n",
       "         'ensure': 295,\n",
       "         'providing': 295,\n",
       "         'haemophiliactransfusion': 295,\n",
       "         'mtct': 294,\n",
       "         'literature': 293,\n",
       "         'resource': 293,\n",
       "         'ed': 292,\n",
       "         'legal': 292,\n",
       "         'given': 291,\n",
       "         'liechtenstein': 290,\n",
       "         'susceptibility': 289,\n",
       "         'ost': 289,\n",
       "         '2002': 288,\n",
       "         'free': 288,\n",
       "         'partially': 288,\n",
       "         'challenge': 288,\n",
       "         '105': 287,\n",
       "         'world': 286,\n",
       "         'without': 285,\n",
       "         'concern': 285,\n",
       "         'network': 285,\n",
       "         'collected': 283,\n",
       "         '99': 283,\n",
       "         'almost': 282,\n",
       "         'hivsti': 282,\n",
       "         'expert': 281,\n",
       "         'political': 281,\n",
       "         'clinical': 281,\n",
       "         '120': 281,\n",
       "         'date': 280,\n",
       "         'highest': 280,\n",
       "         '109': 280,\n",
       "         'development': 279,\n",
       "         'possible': 278,\n",
       "         'difference': 277,\n",
       "         'death': 276,\n",
       "         '500': 276,\n",
       "         'show': 273,\n",
       "         '350': 273,\n",
       "         'previous': 272,\n",
       "         'client': 272,\n",
       "         '116': 271,\n",
       "         'half': 270,\n",
       "         'hospital': 270,\n",
       "         'southeast': 270,\n",
       "         'economic': 269,\n",
       "         'ing': 269,\n",
       "         'undocumented': 269,\n",
       "         '106': 269,\n",
       "         'third': 268,\n",
       "         'identify': 267,\n",
       "         'agency': 267,\n",
       "         'leadership': 266,\n",
       "         'address': 265,\n",
       "         'local': 265,\n",
       "         'targeted': 264,\n",
       "         '111': 263,\n",
       "         'least': 263,\n",
       "         'middle': 263,\n",
       "         'equipment': 263,\n",
       "         'additional': 262,\n",
       "         'recommendation': 261,\n",
       "         'known': 261,\n",
       "         'point': 261,\n",
       "         'на': 261,\n",
       "         '113': 260,\n",
       "         'second': 258,\n",
       "         '114': 258,\n",
       "         'tuberculosis': 258,\n",
       "         'conclusion': 256,\n",
       "         '110': 256,\n",
       "         'situation': 255,\n",
       "         '131': 255,\n",
       "         '107': 255,\n",
       "         '2020': 255,\n",
       "         'document': 254,\n",
       "         'sampling': 254,\n",
       "         'australia': 253,\n",
       "         'acquired': 252,\n",
       "         'systematic': 252,\n",
       "         'priority': 252,\n",
       "         'financial': 252,\n",
       "         'harm': 252,\n",
       "         '125': 252,\n",
       "         '1999': 250,\n",
       "         'scientific': 250,\n",
       "         '119': 250,\n",
       "         'birth': 248,\n",
       "         'topic': 247,\n",
       "         '2001': 247,\n",
       "         '124': 247,\n",
       "         'effect': 246,\n",
       "         '201': 246,\n",
       "         'reduce': 244,\n",
       "         'immigrant': 244,\n",
       "         'good': 242,\n",
       "         'extent': 242,\n",
       "         'common': 241,\n",
       "         '117': 241,\n",
       "         'way': 240,\n",
       "         'availability': 240,\n",
       "         'internet': 240,\n",
       "         '121': 240,\n",
       "         '2017': 239,\n",
       "         'annual': 239,\n",
       "         'gay': 239,\n",
       "         'garp': 239,\n",
       "         'offer': 238,\n",
       "         'mean': 238,\n",
       "         'syringe': 238,\n",
       "         'fight': 235,\n",
       "         'van': 234,\n",
       "         'comparison': 233,\n",
       "         '126': 233,\n",
       "         'reason': 232,\n",
       "         'u': 232,\n",
       "         'andor': 231,\n",
       "         '115': 229,\n",
       "         'towards': 229,\n",
       "         'outbreak': 228,\n",
       "         '132': 228,\n",
       "         'publication': 227,\n",
       "         'zealand': 227,\n",
       "         'published': 226,\n",
       "         'representative': 226,\n",
       "         'reference': 225,\n",
       "         'made': 225,\n",
       "         'delay': 225,\n",
       "         'cell': 225,\n",
       "         '122': 225,\n",
       "         'substitution': 224,\n",
       "         'ie': 223,\n",
       "         'whether': 223,\n",
       "         'category': 222,\n",
       "         'city': 221,\n",
       "         'standard': 221,\n",
       "         'pacific': 220,\n",
       "         'protection': 218,\n",
       "         'intercourse': 218,\n",
       "         '130': 218,\n",
       "         'department': 217,\n",
       "         'needed': 216,\n",
       "         'context': 216,\n",
       "         '118': 216,\n",
       "         '104': 216,\n",
       "         'staff': 216,\n",
       "         'received': 215,\n",
       "         'especially': 215,\n",
       "         'med': 215,\n",
       "         'framework': 215,\n",
       "         'order': 214,\n",
       "         '129': 213,\n",
       "         'still': 213,\n",
       "         'currently': 213,\n",
       "         'se': 213,\n",
       "         '127': 213,\n",
       "         'early': 212,\n",
       "         'associated': 212,\n",
       "         'set': 212,\n",
       "         'chlamydia': 212,\n",
       "         'please': 212,\n",
       "         'e': 211,\n",
       "         'lower': 211,\n",
       "         '108': 210,\n",
       "         'repeated': 209,\n",
       "         'eastern': 209,\n",
       "         'others': 209,\n",
       "         '140': 208,\n",
       "         'problem': 208,\n",
       "         'according': 208,\n",
       "         'organization': 208,\n",
       "         'eea': 208,\n",
       "         'offered': 207,\n",
       "         '143': 207,\n",
       "         'sharing': 207,\n",
       "         'tool': 207,\n",
       "         'monitor': 206,\n",
       "         'primary': 206,\n",
       "         'communicable': 206,\n",
       "         '128': 206,\n",
       "         '157': 206,\n",
       "         'prevent': 205,\n",
       "         'life': 204,\n",
       "         'vaccination': 203,\n",
       "         '144': 203,\n",
       "         'appropriate': 203,\n",
       "         'difficult': 203,\n",
       "         'often': 203,\n",
       "         'start': 202,\n",
       "         'search': 201,\n",
       "         'regarding': 201,\n",
       "         'initiated': 201,\n",
       "         '175': 201,\n",
       "         '148': 200,\n",
       "         '112': 200,\n",
       "         'ncpi': 200,\n",
       "         '136': 199,\n",
       "         'emis': 199,\n",
       "         'around': 198,\n",
       "         '163': 198,\n",
       "         'follow': 197,\n",
       "         'anal': 197,\n",
       "         '149': 197,\n",
       "         'performed': 196,\n",
       "         'eight': 196,\n",
       "         'site': 196,\n",
       "         'iii': 195,\n",
       "         'large': 195,\n",
       "         'excluded': 195,\n",
       "         'nation': 195,\n",
       "         '123': 195,\n",
       "         'campaign': 194,\n",
       "         '146': 194,\n",
       "         'negative': 193,\n",
       "         'случаев': 193,\n",
       "         '137': 192,\n",
       "         '133': 192,\n",
       "         'training': 191,\n",
       "         '150': 191,\n",
       "         'outside': 191,\n",
       "         'exchange': 191,\n",
       "         'therefore': 190,\n",
       "         'ever': 190,\n",
       "         'adult': 189,\n",
       "         'majority': 189,\n",
       "         'includes': 189,\n",
       "         'recommended': 188,\n",
       "         'pre': 188,\n",
       "         '156': 188,\n",
       "         'relatively': 188,\n",
       "         'experience': 188,\n",
       "         'improving': 188,\n",
       "         '138': 188,\n",
       "         'nr': 188,\n",
       "         'take': 187,\n",
       "         '141': 187,\n",
       "         'make': 187,\n",
       "         'benefit': 186,\n",
       "         'suppression': 186,\n",
       "         'seven': 185,\n",
       "         'know': 185,\n",
       "         'notification': 184,\n",
       "         'unit': 184,\n",
       "         'background': 183,\n",
       "         'voluntary': 183,\n",
       "         'role': 183,\n",
       "         '139': 183,\n",
       "         '135': 182,\n",
       "         'paper': 182,\n",
       "         'discussion': 181,\n",
       "         'comprehensive': 181,\n",
       "         'tion': 181,\n",
       "         'design': 181,\n",
       "         'observed': 181,\n",
       "         'past': 181,\n",
       "         'prep': 181,\n",
       "         'routine': 180,\n",
       "         '160': 180,\n",
       "         'distributed': 180,\n",
       "         'done': 180,\n",
       "         'better': 180,\n",
       "         'originating': 180,\n",
       "         '142': 178,\n",
       "         'school': 178,\n",
       "         '171': 177,\n",
       "         '170': 177,\n",
       "         '172': 177,\n",
       "         'hivrelated': 176,\n",
       "         'crosssectional': 176,\n",
       "         '162': 176,\n",
       "         'infect': 175,\n",
       "         '134': 175,\n",
       "         'condition': 174,\n",
       "         'provides': 174,\n",
       "         'nine': 174,\n",
       "         'introduction': 174,\n",
       "         'major': 174,\n",
       "         'opioid': 174,\n",
       "         'working': 174,\n",
       "         'reach': 173,\n",
       "         'week': 173,\n",
       "         '182': 173,\n",
       "         'gender': 172,\n",
       "         'nrc': 171,\n",
       "         '168': 171,\n",
       "         'incidence': 170,\n",
       "         'presentation': 170,\n",
       "         'involvement': 170,\n",
       "         'pwids': 170,\n",
       "         'implemented': 169,\n",
       "         'opportunity': 169,\n",
       "         'joint': 169,\n",
       "         'commitment': 169,\n",
       "         'black': 169,\n",
       "         'required': 168,\n",
       "         'database': 168,\n",
       "         'center': 168,\n",
       "         '161': 168,\n",
       "         'delivery': 167,\n",
       "         '164': 167,\n",
       "         'decline': 166,\n",
       "         'decrease': 166,\n",
       "         'undiagnosed': 166,\n",
       "         'end': 166,\n",
       "         'similar': 165,\n",
       "         '179': 165,\n",
       "         '300': 165,\n",
       "         'promotion': 165,\n",
       "         'suggested': 164,\n",
       "         'opinion': 164,\n",
       "         '181': 164,\n",
       "         'pattern': 164,\n",
       "         '145': 164,\n",
       "         '167': 164,\n",
       "         'present': 163,\n",
       "         'commented': 163,\n",
       "         'variable': 163,\n",
       "         'even': 162,\n",
       "         '169': 162,\n",
       "         '153': 161,\n",
       "         'noted': 161,\n",
       "         'western': 161,\n",
       "         'delivered': 160,\n",
       "         'regulation': 160,\n",
       "         'outreach': 160,\n",
       "         '196': 160,\n",
       "         '158': 160,\n",
       "         'eur': 159,\n",
       "         'reached': 159,\n",
       "         'conference': 159,\n",
       "         '178': 159,\n",
       "         '211': 158,\n",
       "         'line': 158,\n",
       "         'body': 157,\n",
       "         'mapping': 157,\n",
       "         '299': 157,\n",
       "         '222': 156,\n",
       "         'element': 156,\n",
       "         'anonymous': 156,\n",
       "         'clear': 156,\n",
       "         'spending': 156,\n",
       "         '189': 156,\n",
       "         'advice': 156,\n",
       "         '154': 156,\n",
       "         'defined': 155,\n",
       "         'language': 155,\n",
       "         'account': 155,\n",
       "         'difficulty': 155,\n",
       "         'developed': 154,\n",
       "         'statistic': 154,\n",
       "         'note': 154,\n",
       "         'like': 154,\n",
       "         '2023': 154,\n",
       "         'covered': 153,\n",
       "         'focused': 153,\n",
       "         '151': 153,\n",
       "         'idus': 153,\n",
       "         'purpose': 152,\n",
       "         'existing': 152,\n",
       "         'ass': 152,\n",
       "         'entry': 152,\n",
       "         '180': 152,\n",
       "         'congenital': 151,\n",
       "         'agreed': 151,\n",
       "         'another': 151,\n",
       "         'overview': 151,\n",
       "         'regular': 151,\n",
       "         '159': 151,\n",
       "         '147': 151,\n",
       "         'collect': 150,\n",
       "         'improved': 150,\n",
       "         '152': 150,\n",
       "         'russian': 150,\n",
       "         '214': 150,\n",
       "         'grade': 150,\n",
       "         'mechanism': 149,\n",
       "         'peer': 149,\n",
       "         'self': 148,\n",
       "         'casual': 148,\n",
       "         '176': 148,\n",
       "         'importance': 147,\n",
       "         'gap': 147,\n",
       "         'unprotected': 147,\n",
       "         '183': 147,\n",
       "         'stated': 146,\n",
       "         'eurohiv': 146,\n",
       "         '244': 146,\n",
       "         'вичинфекции': 146,\n",
       "         'n=0': 146,\n",
       "         'submitted': 145,\n",
       "         'professional': 145,\n",
       "         'january': 144,\n",
       "         'accessing': 144,\n",
       "         'demographic': 144,\n",
       "         'comparability': 144,\n",
       "         'met': 143,\n",
       "         'receive': 143,\n",
       "         '173': 143,\n",
       "         'en': 143,\n",
       "         'brief': 143,\n",
       "         'remains': 143,\n",
       "         '193': 143,\n",
       "         'program': 142,\n",
       "         'decreased': 142,\n",
       "         'england': 142,\n",
       "         'wide': 142,\n",
       "         'planning': 142,\n",
       "         'consistently': 142,\n",
       "         'distribution': 142,\n",
       "         'list': 142,\n",
       "         'summary': 141,\n",
       "         '185': 141,\n",
       "         'characteristic': 141,\n",
       "         '203': 141,\n",
       "         'adjusted': 140,\n",
       "         'generation': 140,\n",
       "         'sterile': 140,\n",
       "         '20–24': 140,\n",
       "         '218': 140,\n",
       "         'value': 139,\n",
       "         'std': 139,\n",
       "         'coordination': 139,\n",
       "         '250': 138,\n",
       "         '184': 138,\n",
       "         'fear': 138,\n",
       "         '205': 138,\n",
       "         'aim': 137,\n",
       "         'objective': 137,\n",
       "         'showed': 137,\n",
       "         'awareness': 137,\n",
       "         'nationality': 137,\n",
       "         '198': 137,\n",
       "         'remain': 137,\n",
       "         'always': 137,\n",
       "         'contribution': 137,\n",
       "         'name': 137,\n",
       "         'help': 137,\n",
       "         'un': 136,\n",
       "         'hivpositive': 136,\n",
       "         'excluding': 136,\n",
       "         'established': 136,\n",
       "         'essential': 136,\n",
       "         'institution': 136,\n",
       "         '174': 136,\n",
       "         '202': 136,\n",
       "         '221': 135,\n",
       "         'tochild': 135,\n",
       "         'taken': 135,\n",
       "         '194': 135,\n",
       "         'develop': 135,\n",
       "         'website': 135,\n",
       "         '204': 135,\n",
       "         '31122020': 135,\n",
       "         'diagnostic': 134,\n",
       "         '166': 134,\n",
       "         'preventive': 133,\n",
       "         ...})"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "word_counts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0     [11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 1...\n",
       "1              [11, 11, 11, 11, 11, 11, 11, 11, 11, 11]\n",
       "2     [11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 1...\n",
       "3     [11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 1...\n",
       "4     [11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 1...\n",
       "                            ...                        \n",
       "67     [11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11]\n",
       "68    [11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 1...\n",
       "69                                 [11, 11, 11, 11, 11]\n",
       "70    [11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 1...\n",
       "71    [11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 1...\n",
       "Name: text_modified, Length: 72, dtype: object"
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pattern = r'11'\n",
    "match = harvest_nlp['text_modified'].str.findall(pattern)\n",
    "match"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['2017',\n",
       " '2017',\n",
       " '2011',\n",
       " '2014',\n",
       " '2011',\n",
       " '2011',\n",
       " '1990',\n",
       " '2011',\n",
       " '2012',\n",
       " '2012',\n",
       " '2014',\n",
       " '2000',\n",
       " '2014',\n",
       " '2011',\n",
       " '2012',\n",
       " '2012',\n",
       " '2014',\n",
       " '2014',\n",
       " '1982',\n",
       " '2003',\n",
       " '1987',\n",
       " '1985',\n",
       " '1993',\n",
       " '1994',\n",
       " '1998',\n",
       " '1999',\n",
       " '2003',\n",
       " '2000',\n",
       " '2005',\n",
       " '2004',\n",
       " '1999',\n",
       " '2006',\n",
       " '1991',\n",
       " '2002',\n",
       " '2001',\n",
       " '1988',\n",
       " '2008',\n",
       " '1997',\n",
       " '2002',\n",
       " '1997',\n",
       " '2008',\n",
       " '1996',\n",
       " '2000',\n",
       " '2002',\n",
       " '2005',\n",
       " '1997',\n",
       " '2000',\n",
       " '2001',\n",
       " '2000',\n",
       " '2008',\n",
       " '2004',\n",
       " '2004',\n",
       " '2004',\n",
       " '1999',\n",
       " '2003',\n",
       " '2003',\n",
       " '2003',\n",
       " '2000',\n",
       " '2004',\n",
       " '2000',\n",
       " '1996',\n",
       " '2000',\n",
       " '1996',\n",
       " '1987',\n",
       " '2002',\n",
       " '1996',\n",
       " '1996',\n",
       " '2002',\n",
       " '1987',\n",
       " '1995',\n",
       " '1996',\n",
       " '2002',\n",
       " '1999',\n",
       " '1999',\n",
       " '2010',\n",
       " '2002',\n",
       " '2004',\n",
       " '2002',\n",
       " '2004',\n",
       " '2005',\n",
       " '1984',\n",
       " '2007',\n",
       " '1984',\n",
       " '1986',\n",
       " '1996',\n",
       " '1998',\n",
       " '2002',\n",
       " '2004',\n",
       " '1997',\n",
       " '2004',\n",
       " '2001',\n",
       " '2006',\n",
       " '2008',\n",
       " '2004',\n",
       " '2008',\n",
       " '2004',\n",
       " '2003',\n",
       " '1425',\n",
       " '1998',\n",
       " '2001',\n",
       " '2008',\n",
       " '2009',\n",
       " '2005',\n",
       " '1989',\n",
       " '1993',\n",
       " '1998',\n",
       " '2008',\n",
       " '1997',\n",
       " '1996',\n",
       " '1993',\n",
       " '2006',\n",
       " '2011',\n",
       " '1999',\n",
       " '2006',\n",
       " '2009',\n",
       " '2008',\n",
       " '1999',\n",
       " '2006',\n",
       " '2007',\n",
       " '1990',\n",
       " '2000',\n",
       " '1983',\n",
       " '1990',\n",
       " '1983',\n",
       " '2009',\n",
       " '1995',\n",
       " '2008',\n",
       " '2004',\n",
       " '2007',\n",
       " '2010',\n",
       " '2004',\n",
       " '2005',\n",
       " '2010',\n",
       " '2004',\n",
       " '2005',\n",
       " '2425',\n",
       " '2008',\n",
       " '2004',\n",
       " '2003',\n",
       " '1997',\n",
       " '1996',\n",
       " '1993',\n",
       " '2000',\n",
       " '1983',\n",
       " '2009',\n",
       " '2008',\n",
       " '2004',\n",
       " '2003',\n",
       " '1997',\n",
       " '1996',\n",
       " '1993',\n",
       " '2000',\n",
       " '1983',\n",
       " '2009',\n",
       " '2008',\n",
       " '2005',\n",
       " '2016',\n",
       " '1982',\n",
       " '2003',\n",
       " '2006',\n",
       " '2008',\n",
       " '1999',\n",
       " '2006',\n",
       " '2009',\n",
       " '1985',\n",
       " '2005',\n",
       " '2006',\n",
       " '1988',\n",
       " '2008',\n",
       " '2010',\n",
       " '1996',\n",
       " '2000',\n",
       " '2003',\n",
       " '2007',\n",
       " '2011',\n",
       " '1998',\n",
       " '2001',\n",
       " '2002',\n",
       " '2007',\n",
       " '2007',\n",
       " '2007',\n",
       " '2007',\n",
       " '2005',\n",
       " '2008',\n",
       " '2002',\n",
       " '2004',\n",
       " '2002',\n",
       " '2004',\n",
       " '2007',\n",
       " '2007',\n",
       " '2008',\n",
       " '2004',\n",
       " '2003',\n",
       " '2003',\n",
       " '2011',\n",
       " '2011',\n",
       " '2001',\n",
       " '2012',\n",
       " '1992',\n",
       " '2009',\n",
       " '2011',\n",
       " '1993',\n",
       " '1998',\n",
       " '2001',\n",
       " '2711',\n",
       " '1992',\n",
       " '1999',\n",
       " '2004',\n",
       " '1996',\n",
       " '1993',\n",
       " '2006',\n",
       " '2003',\n",
       " '2004',\n",
       " '2011',\n",
       " '2012',\n",
       " '2012',\n",
       " '1983',\n",
       " '2010',\n",
       " '2004',\n",
       " '2004',\n",
       " '2009',\n",
       " '2012',\n",
       " '2005',\n",
       " '2009',\n",
       " '2011',\n",
       " '2013',\n",
       " '1998',\n",
       " '2011',\n",
       " '2012',\n",
       " '2958',\n",
       " '1384',\n",
       " '1519',\n",
       " '1714',\n",
       " '1698',\n",
       " '2149',\n",
       " '1882',\n",
       " '2995',\n",
       " '1980',\n",
       " '1990',\n",
       " '1111',\n",
       " '1084',\n",
       " '1325',\n",
       " '1781',\n",
       " '2039',\n",
       " '1714',\n",
       " '2000',\n",
       " '2000',\n",
       " '2000',\n",
       " '2000',\n",
       " '2010',\n",
       " '2010',\n",
       " '2010',\n",
       " '2009',\n",
       " '2010',\n",
       " '2010',\n",
       " '2122',\n",
       " '2010',\n",
       " '2010',\n",
       " '2010',\n",
       " '2010',\n",
       " '2004',\n",
       " '2009',\n",
       " '2013',\n",
       " '2005',\n",
       " '2007',\n",
       " '2002',\n",
       " '2008',\n",
       " '2008',\n",
       " '2010',\n",
       " '2008',\n",
       " '2010',\n",
       " '2010',\n",
       " '2004',\n",
       " '2008',\n",
       " '2008',\n",
       " '2010',\n",
       " '2009',\n",
       " '2008',\n",
       " '2000',\n",
       " '2000',\n",
       " '2008',\n",
       " '2008',\n",
       " '2000',\n",
       " '2008',\n",
       " '2008',\n",
       " '2008',\n",
       " '2009',\n",
       " '2010',\n",
       " '2008',\n",
       " '2008',\n",
       " '2010',\n",
       " '2010',\n",
       " '2010',\n",
       " '2005',\n",
       " '2007',\n",
       " '2007',\n",
       " '2010',\n",
       " '2008',\n",
       " '2010',\n",
       " '2008',\n",
       " '2001',\n",
       " '2002',\n",
       " '2008',\n",
       " '2004',\n",
       " '2002',\n",
       " '2008',\n",
       " '2008',\n",
       " '2009',\n",
       " '2006',\n",
       " '2002',\n",
       " '2003',\n",
       " '2004',\n",
       " '2005',\n",
       " '2006',\n",
       " '2007',\n",
       " '2010',\n",
       " '2008',\n",
       " '2001',\n",
       " '2008',\n",
       " '2001',\n",
       " '2009',\n",
       " '2008',\n",
       " '2009',\n",
       " '2003',\n",
       " '2004',\n",
       " '2005',\n",
       " '2006',\n",
       " '2007',\n",
       " '2010',\n",
       " '2008',\n",
       " '2009',\n",
       " '2000',\n",
       " '2006',\n",
       " '2006',\n",
       " '2008',\n",
       " '2006',\n",
       " '2007',\n",
       " '2008',\n",
       " '2000',\n",
       " '2009',\n",
       " '2000',\n",
       " '2001',\n",
       " '2002',\n",
       " '2003',\n",
       " '2004',\n",
       " '2005',\n",
       " '2006',\n",
       " '2007',\n",
       " '2010',\n",
       " '2010',\n",
       " '2010',\n",
       " '2010',\n",
       " '2010',\n",
       " '2009',\n",
       " '2009',\n",
       " '2010',\n",
       " '2010',\n",
       " '2010',\n",
       " '2010',\n",
       " '2010',\n",
       " '2010',\n",
       " '2010',\n",
       " '2010',\n",
       " '2010',\n",
       " '2010',\n",
       " '2010',\n",
       " '2010',\n",
       " '2010',\n",
       " '2010',\n",
       " '2004',\n",
       " '2005',\n",
       " '2006',\n",
       " '2007',\n",
       " '2005',\n",
       " '2006',\n",
       " '2007',\n",
       " '2005',\n",
       " '2006',\n",
       " '2007',\n",
       " '2010',\n",
       " '2007',\n",
       " '2008',\n",
       " '2008',\n",
       " '2009',\n",
       " '2010',\n",
       " '2010',\n",
       " '1989',\n",
       " '2001',\n",
       " '2006',\n",
       " '2010',\n",
       " '2010',\n",
       " '2010',\n",
       " '2010',\n",
       " '2001',\n",
       " '2004',\n",
       " '2006',\n",
       " '2008',\n",
       " '2010',\n",
       " '2008',\n",
       " '2004',\n",
       " '2006',\n",
       " '2008',\n",
       " '2010',\n",
       " '2008',\n",
       " '2008',\n",
       " '2009',\n",
       " '2010',\n",
       " '2005',\n",
       " '2007',\n",
       " '2004',\n",
       " '2004',\n",
       " '2010',\n",
       " '2014',\n",
       " '2014',\n",
       " '2014',\n",
       " '2014',\n",
       " '2015',\n",
       " '2015',\n",
       " '2015',\n",
       " '2014',\n",
       " '1244',\n",
       " '2014',\n",
       " '2011',\n",
       " '2013',\n",
       " '2011',\n",
       " '2013',\n",
       " '2011',\n",
       " '2013',\n",
       " '2014',\n",
       " '2014',\n",
       " '2014',\n",
       " '2012',\n",
       " '2014',\n",
       " '2004',\n",
       " '2015',\n",
       " '2009',\n",
       " '2014',\n",
       " '2012',\n",
       " '2014',\n",
       " '2013',\n",
       " '2012',\n",
       " '2012',\n",
       " '2014',\n",
       " '2014',\n",
       " '2014',\n",
       " '2012',\n",
       " '2014',\n",
       " '2012',\n",
       " '2014',\n",
       " '2011',\n",
       " '2014',\n",
       " '2012',\n",
       " '2014',\n",
       " '2012',\n",
       " '2014',\n",
       " '2011',\n",
       " '2922',\n",
       " '2730',\n",
       " '1218',\n",
       " '2014',\n",
       " '2012',\n",
       " '2014',\n",
       " '2014',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2007',\n",
       " '2012',\n",
       " '2011',\n",
       " '2012',\n",
       " '2011',\n",
       " '2011',\n",
       " '2001',\n",
       " '2010',\n",
       " '2011',\n",
       " '2011',\n",
       " '2011',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '1992',\n",
       " '1984',\n",
       " '1998',\n",
       " '2012',\n",
       " '2009',\n",
       " '2009',\n",
       " '2010',\n",
       " '2010',\n",
       " '2011',\n",
       " '2010',\n",
       " '2011',\n",
       " '2010',\n",
       " '2012',\n",
       " '2010',\n",
       " '2011',\n",
       " '2012',\n",
       " '2010',\n",
       " '2012',\n",
       " '1981',\n",
       " '2011',\n",
       " '2011',\n",
       " '2001',\n",
       " '2011',\n",
       " '2011',\n",
       " '2011',\n",
       " '2012',\n",
       " '2011',\n",
       " '2012',\n",
       " '2011',\n",
       " '2012',\n",
       " '2011',\n",
       " '2012',\n",
       " '2012',\n",
       " '2007',\n",
       " '2012',\n",
       " '2012',\n",
       " '2007',\n",
       " '2007',\n",
       " '1981',\n",
       " '1983',\n",
       " '1985',\n",
       " '1987',\n",
       " '1989',\n",
       " '1991',\n",
       " '1993',\n",
       " '1995',\n",
       " '1997',\n",
       " '1999',\n",
       " '2001',\n",
       " '2003',\n",
       " '2005',\n",
       " '2007',\n",
       " '2009',\n",
       " '2011',\n",
       " '2001',\n",
       " '2002',\n",
       " '2003',\n",
       " '2004',\n",
       " '2005',\n",
       " '2006',\n",
       " '2007',\n",
       " '2008',\n",
       " '2009',\n",
       " '2010',\n",
       " '2007',\n",
       " '2012',\n",
       " '2011',\n",
       " '2012',\n",
       " '2011',\n",
       " '2007',\n",
       " '2010',\n",
       " '2011',\n",
       " '2012',\n",
       " '2012',\n",
       " '2011',\n",
       " '2012',\n",
       " '2011',\n",
       " '2007',\n",
       " '2008',\n",
       " '2009',\n",
       " '2010',\n",
       " '2011',\n",
       " '2012',\n",
       " '2011',\n",
       " '1998',\n",
       " '2009',\n",
       " '2010',\n",
       " '2010',\n",
       " '1985',\n",
       " '2012',\n",
       " '2008',\n",
       " '2012',\n",
       " '2011',\n",
       " '2012',\n",
       " '2002',\n",
       " '2012',\n",
       " '2007',\n",
       " '2012',\n",
       " '2002',\n",
       " '2011',\n",
       " '2008',\n",
       " '2011',\n",
       " '2010',\n",
       " '2011',\n",
       " '2008',\n",
       " '2011',\n",
       " '2011',\n",
       " '2012',\n",
       " '2012',\n",
       " '2007',\n",
       " '2011',\n",
       " '2011',\n",
       " '2007',\n",
       " '2011',\n",
       " '2011',\n",
       " '2009',\n",
       " '2010',\n",
       " '2007',\n",
       " '2008',\n",
       " '2009',\n",
       " '2010',\n",
       " '2011',\n",
       " '2534',\n",
       " '2010',\n",
       " '2011',\n",
       " '2010',\n",
       " '2011',\n",
       " '2006',\n",
       " '2010',\n",
       " '2006',\n",
       " '2012',\n",
       " '2012',\n",
       " '2011',\n",
       " '2011',\n",
       " '2012',\n",
       " '2007',\n",
       " '2011',\n",
       " '2012',\n",
       " '2008',\n",
       " '2012',\n",
       " '2005',\n",
       " '2011',\n",
       " '2000',\n",
       " '1998',\n",
       " '2000',\n",
       " '1998',\n",
       " '2007',\n",
       " '2012',\n",
       " '2010',\n",
       " '2011',\n",
       " '2010',\n",
       " '2008',\n",
       " '2012',\n",
       " '2004',\n",
       " '2012',\n",
       " '2012',\n",
       " '2004',\n",
       " '2012',\n",
       " '2012',\n",
       " '2007',\n",
       " '2011',\n",
       " '2010',\n",
       " '2010',\n",
       " '2007',\n",
       " '2009',\n",
       " '1990',\n",
       " '2010',\n",
       " '1994',\n",
       " '2012',\n",
       " '2012',\n",
       " '2009',\n",
       " '2012',\n",
       " '2009',\n",
       " '2010',\n",
       " '2011',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2010',\n",
       " '2008',\n",
       " '2012',\n",
       " '2008',\n",
       " '2012',\n",
       " '2008',\n",
       " '2009',\n",
       " '2010',\n",
       " '2011',\n",
       " '2012',\n",
       " '2011',\n",
       " '2012',\n",
       " '2012',\n",
       " '2010',\n",
       " '2008',\n",
       " '2009',\n",
       " '2012',\n",
       " '2012',\n",
       " '2011',\n",
       " '2012',\n",
       " '1993',\n",
       " '2012',\n",
       " '1996',\n",
       " '2010',\n",
       " '2010',\n",
       " '2012',\n",
       " '2012',\n",
       " '2011',\n",
       " '2012',\n",
       " '2010',\n",
       " '2012',\n",
       " '2011',\n",
       " '2012',\n",
       " '2010',\n",
       " '2011',\n",
       " '2010',\n",
       " '2011',\n",
       " '2012',\n",
       " '2011',\n",
       " '2005',\n",
       " '2012',\n",
       " '2005',\n",
       " '2007',\n",
       " '2008',\n",
       " '2009',\n",
       " '2010',\n",
       " '2011',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2008',\n",
       " '2011',\n",
       " '2012',\n",
       " '2012',\n",
       " '2013',\n",
       " '2007',\n",
       " '2013',\n",
       " '2011',\n",
       " '2409',\n",
       " '2012',\n",
       " '2011',\n",
       " '2012',\n",
       " '2011',\n",
       " '2012',\n",
       " '2011',\n",
       " '2012',\n",
       " '2011',\n",
       " '2012',\n",
       " '2011',\n",
       " '2012',\n",
       " '2011',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2011',\n",
       " '2011',\n",
       " '2011',\n",
       " '2010',\n",
       " '2011',\n",
       " '1992',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2011',\n",
       " '2012',\n",
       " '2012',\n",
       " '1998',\n",
       " '2011',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2010',\n",
       " '2009',\n",
       " '2011',\n",
       " '2010',\n",
       " '2014',\n",
       " '2012',\n",
       " '2011',\n",
       " '2012',\n",
       " '2011',\n",
       " '2011',\n",
       " '2012',\n",
       " '2013',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2007',\n",
       " '2012',\n",
       " '2007',\n",
       " '2008',\n",
       " '2009',\n",
       " '2010',\n",
       " '2011',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2011',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2011',\n",
       " '2011',\n",
       " '2009',\n",
       " '2010',\n",
       " '2007',\n",
       " '2012',\n",
       " '2012',\n",
       " '2010',\n",
       " '2011',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2011',\n",
       " '1990',\n",
       " '2010',\n",
       " '2012',\n",
       " '2010',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2011',\n",
       " '2005',\n",
       " '2009',\n",
       " '2005',\n",
       " '2006',\n",
       " '2012',\n",
       " '2012',\n",
       " '2011',\n",
       " '2012',\n",
       " '2012',\n",
       " '2022',\n",
       " '2001',\n",
       " '1998',\n",
       " '2000',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2010',\n",
       " '2012',\n",
       " '2012',\n",
       " '2012',\n",
       " '2009',\n",
       " '2011',\n",
       " '2011',\n",
       " '2011',\n",
       " '2009',\n",
       " '2011',\n",
       " '2007',\n",
       " '2011',\n",
       " '2007',\n",
       " '2010',\n",
       " '2009',\n",
       " '2010',\n",
       " '2011',\n",
       " '2011',\n",
       " '2011',\n",
       " '2011',\n",
       " '2011',\n",
       " '2012',\n",
       " '2022',\n",
       " '2024',\n",
       " '2024',\n",
       " '2022',\n",
       " '2021',\n",
       " '2018',\n",
       " '2019',\n",
       " '2020',\n",
       " '2021',\n",
       " '2022',\n",
       " '2022',\n",
       " '2021',\n",
       " '2018',\n",
       " '2022',\n",
       " '2022',\n",
       " '2024',\n",
       " '2022',\n",
       " '2022',\n",
       " '2022',\n",
       " '2327',\n",
       " '2015',\n",
       " '2022',\n",
       " '2012',\n",
       " '2013',\n",
       " '2022',\n",
       " '2013',\n",
       " '2022',\n",
       " '2013',\n",
       " '2019',\n",
       " '2018',\n",
       " '2020',\n",
       " '2013',\n",
       " '2019',\n",
       " '2020',\n",
       " '2020',\n",
       " '2019',\n",
       " '2022',\n",
       " '2022',\n",
       " '2022',\n",
       " '2018',\n",
       " '2022',\n",
       " '2018',\n",
       " '2019',\n",
       " '2020',\n",
       " '2021',\n",
       " '2022',\n",
       " '2692',\n",
       " '2932',\n",
       " '2946',\n",
       " '1642',\n",
       " '1878',\n",
       " '1390',\n",
       " '1662',\n",
       " '1923',\n",
       " '1602',\n",
       " '1790',\n",
       " '2366',\n",
       " '2907',\n",
       " '1461',\n",
       " '1572',\n",
       " '2020',\n",
       " '2020',\n",
       " '2020',\n",
       " '2020',\n",
       " '2022',\n",
       " '2022',\n",
       " '2022',\n",
       " '2022',\n",
       " '2022',\n",
       " '2022',\n",
       " '2022',\n",
       " '2022',\n",
       " '2022',\n",
       " '2022',\n",
       " '2022',\n",
       " '2022',\n",
       " '2013',\n",
       " '2022',\n",
       " '2013',\n",
       " '2022',\n",
       " '2013',\n",
       " '2017',\n",
       " '2021',\n",
       " '2022',\n",
       " '2020',\n",
       " '2022',\n",
       " '2014',\n",
       " '2022',\n",
       " '2013',\n",
       " '2019',\n",
       " '2020',\n",
       " '2013',\n",
       " '2022',\n",
       " '2013',\n",
       " '2022',\n",
       " '2019',\n",
       " '2020',\n",
       " '2021',\n",
       " '2022',\n",
       " '2021',\n",
       " '2018',\n",
       " '2022',\n",
       " '2018',\n",
       " '2022',\n",
       " '2022',\n",
       " '2018',\n",
       " '2022',\n",
       " '2018',\n",
       " '2022',\n",
       " '2013',\n",
       " '2022',\n",
       " '2022',\n",
       " '2022',\n",
       " '2022',\n",
       " '2022',\n",
       " '2020',\n",
       " '2021',\n",
       " '2022',\n",
       " '2022',\n",
       " '2022',\n",
       " '1214',\n",
       " '2022',\n",
       " '2016',\n",
       " '2024',\n",
       " '2030',\n",
       " '2022',\n",
       " '2015',\n",
       " '2022',\n",
       " '2024',\n",
       " '2017',\n",
       " '2018',\n",
       " '2021',\n",
       " '2014',\n",
       " '2014',\n",
       " '2021',\n",
       " '2021',\n",
       " '2022',\n",
       " '2022',\n",
       " '2022',\n",
       " ...]"
      ]
     },
     "execution_count": 36,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "hi = []\n",
    "for description in harvest_nlp['text_modified']:\n",
    "\tfound = re.findall(pattern,description)\n",
    "\tif (len(found)!=0):\n",
    "\t\thi.append(found)\n",
    "hi = sum(hi,[])\n",
    "hi"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Modeling"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 100,
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.model_selection import train_test_split\n",
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "\n",
    "\n",
    "X_train, X_test , y_train, y_test = train_test_split(harvest_nlp['text_modified'].values,harvest_nlp['is_relevant'].values,\n",
    "\t\t\t\t\t\t\t\t\t\t\t\t\t test_size=0.25,\n",
    "\t\t\t\t\t\t\t\t\t\t\t\t\t random_state=42,\n",
    "\t\t\t\t\t\t\t\t\t\t\t\t\t stratify=harvest_nlp['is_relevant'].values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 99,
   "metadata": {},
   "outputs": [],
   "source": [
    "tfidf_vectorizer = TfidfVectorizer(max_features=3000) #play around with this\n",
    "tfidf_train_vectors = tfidf_vectorizer.fit_transform(X_train)\n",
    "tfidf_test_vectors = tfidf_vectorizer.transform(X_test)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 101,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(54, 3000)"
      ]
     },
     "execution_count": 101,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tfidf_train_vectors.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 102,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<54x3000 sparse matrix of type '<class 'numpy.float64'>'\n",
       "\twith 53248 stored elements in Compressed Sparse Row format>"
      ]
     },
     "execution_count": 102,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tfidf_train_vectors"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 103,
   "metadata": {},
   "outputs": [],
   "source": [
    "classifier = LogisticRegression()\n",
    "classifier.fit(tfidf_train_vectors,y_train)\n",
    "y_pred = classifier.predict(tfidf_test_vectors)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 104,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "              precision    recall  f1-score   support\n",
      "\n",
      "           0       0.89      1.00      0.94        16\n",
      "           1       0.00      0.00      0.00         2\n",
      "\n",
      "    accuracy                           0.89        18\n",
      "   macro avg       0.44      0.50      0.47        18\n",
      "weighted avg       0.79      0.89      0.84        18\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/kevingui/anaconda3/envs/work/lib/python3.11/site-packages/sklearn/metrics/_classification.py:1497: UndefinedMetricWarning: Precision is ill-defined and being set to 0.0 in labels with no predicted samples. Use `zero_division` parameter to control this behavior.\n",
      "  _warn_prf(average, modifier, f\"{metric.capitalize()} is\", len(result))\n",
      "/Users/kevingui/anaconda3/envs/work/lib/python3.11/site-packages/sklearn/metrics/_classification.py:1497: UndefinedMetricWarning: Precision is ill-defined and being set to 0.0 in labels with no predicted samples. Use `zero_division` parameter to control this behavior.\n",
      "  _warn_prf(average, modifier, f\"{metric.capitalize()} is\", len(result))\n",
      "/Users/kevingui/anaconda3/envs/work/lib/python3.11/site-packages/sklearn/metrics/_classification.py:1497: UndefinedMetricWarning: Precision is ill-defined and being set to 0.0 in labels with no predicted samples. Use `zero_division` parameter to control this behavior.\n",
      "  _warn_prf(average, modifier, f\"{metric.capitalize()} is\", len(result))\n"
     ]
    }
   ],
   "source": [
    "print(classification_report(y_test,y_pred))"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "work",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
